cephalosporin c has been researched along with ciprofloxacin in 348 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (5.46) | 18.7374 |
| 1990's | 134 (38.51) | 18.2507 |
| 2000's | 96 (27.59) | 29.6817 |
| 2010's | 83 (23.85) | 24.3611 |
| 2020's | 16 (4.60) | 2.80 |
| Authors | Studies |
|---|---|
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Bartlett, RC; Mazens-Sullivan, MF; McCarter, YS | 1 |
| Johnson, DM; Jones, RN | 1 |
| Allard, S; Auger, F; Bisson, C; Daviau, N; Drapeau, C; LeBel, M; Paradis, D; Vallée, F | 1 |
| Bertasso, A; Georgopapadakou, NH; Pace, J | 1 |
| Albrecht, HA; Beskid, G; Christenson, JG; Georgopapadakou, NH; Keith, DD; Konzelmann, FM; Pruess, DL; Rossman, PL; Wei, CC | 1 |
| Bale, MJ; Doebbeling, BN; Pfaller, MA; Wenzel, RP | 1 |
| Cunningham, MD; Darveau, RP | 1 |
| Albrecht, HA; Beskid, G; Chan, KK; Christenson, JG; Cleeland, R; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Pruess, DL; Sepinwall, J | 1 |
| Fujimoto, T; Mitsuhashi, S | 1 |
| Boothman, C; King, A; Phillips, I | 1 |
| Pennington, JE | 1 |
| Gadebusch, HH; Gilfillan, EC; Pelak, BA; Valiant, ME | 1 |
| Daschner, F; Kropec, A | 1 |
| Bertasso, A; Chan, KK; Chapman, JS; Cleeland, R; Cummings, LM; Dix, BA; Georgopapadakou, NH; Keith, DD | 1 |
| Beskid, G; Chan, K; Cleeland, R; Fallat, V; Keith, DD; Lipschitz, ER; McGarry, DH; Unowsky, J | 1 |
| Bartmann, K; Tarbuc, R | 1 |
| Ingerman, MJ; Levison, ME; Pitsakis, PG; Rosenberg, AF | 1 |
| Forsgren, A; Persson, KM | 1 |
| Brunham, RC; Le Saux, NM; Plummer, FA; Ronald, AR; Slaney, LA | 1 |
| Easmon, CS; Ison, CA; Woodford, N | 1 |
| Hohl, P; Kafader, FM; Salfinger, M | 1 |
| Hardegger, U; Wüst, J | 1 |
| Daikos, GL; Jackson, GG; Lolans, VT | 1 |
| Butzler, JP; Coignau, H; De Mol, P; Ghysels, G; Goossens, H; Grados, O; Innocent, H; Levy, J | 1 |
| Citron, DM; Goldstein, EJ | 1 |
| Williams, P | 1 |
| Alvarez, ME; Bodey, GP; Hsu, KC; Rolston, KV | 1 |
| Appelbaum, PC; Sollenberger, L; Spangler, SK | 1 |
| Neu, HC | 1 |
| Fu, KP; Gregory, FJ; Hetzel, N; Hung, PP | 1 |
| Dalman, P; Drott, C; Holm, J; Ivarsson, L; Jivegård, L; Karlström, L; Odén, A; Pedersen, P; Rahm, V; Risberg, B | 1 |
| Azizi, SA; Fayad, PB; Fulbright, R; Giroux, ML; Waxman, SG | 1 |
| Cellesi, C; Mencarelli, M; Rossolini, A; Sansoni, A; Zanchi, A | 1 |
| Grasmug, E; Hammer, HF; Hoefler, G; Reisinger, EC; Stauber, RE; Trauner, M | 1 |
| Amyes, SG; Baird, DR; Crook, DW; Gillespie, SH; Howard, AJ; Lawrie, SA; Oppenhiem, BA; Paull, A; Pedler, SJ; Tompkins, DS | 1 |
| Cheng, DL; Huang, WK; Liu, YC | 1 |
| Buch, NA; Hassan, MU; Kakroo, DK | 1 |
| Jones, RN; Marshall, SA | 1 |
| Jones, RN; Sanchez, ML | 1 |
| Carret, G; Flandrois, JP; Guérillot, F | 1 |
| Guan, L; Li, LJ; Wei, DJ | 1 |
| Bello, H; Dominguez, M; Garcia, A; Gonzalez, G; Mella, S; Zemelman, R | 1 |
| Blumberg, EA; Kutalek, SP; Reboli, AC; Spratt, KA; Wood, CA | 1 |
| Albrecht, HA; Beskid, G; Christenson, JG; Deitcher, KH; Georgopapadakou, NH; Keith, DD; Konzelmann, FM; Pruess, DL; Wei, CC | 1 |
| Belcher, J; Cole, PJ; Kanthakumar, K; Lund, V; Read, RC; Roberts, DE; Rutman, A; Tsang, KW; Wilson, R | 1 |
| Bonner, DP; Fung-Tomc, J; Kolek, B | 1 |
| Benson, CA; Harrison, B; Levin, JM; Nelson, JA; Segreti, J; Strle, F | 1 |
| Bertasso, A; Georgopapadakou, NH | 1 |
| Grøndahl, TO; Langmoen, IA | 1 |
| Kanchanapongkul, J | 1 |
| Fenelon, LE; MacGowan, AP; Reeves, DS; Smyth, EG; Speirs, GE; Speller, DC; Wilcox, MH | 1 |
| Handa, T; Miyamoto, H; Murase, M; Saheki, S; Takeuchi, N | 1 |
| Kahn, JB; Peterson, LR; Ristow, TA | 1 |
| Chapman, RW; Culshaw, KD; Mehal, WZ; Tillotson, GS | 1 |
| Brouqui, P; Drancourt, M; Raoult, D; Rousseau, MC; Stein, A | 1 |
| Klepser, ME; Nicolau, DP; Nightingale, CH; Patel, KB; Quintiliani, R | 1 |
| Blondeau, JM; Yaschuk, Y | 1 |
| Coughlan, EP; Franklin, RA | 1 |
| Dalhoff, A; Nitsche, D; Oesser, S; Sack, M; Schulze, C | 1 |
| Cisterna, R; Farga, MA; Garau, J; García-de-Lomas, J; Gimeno, C; Millás, E; Navarro, D; Savall, F | 1 |
| Briggs, RJ; Fabinyi, G; Kamarulzaman, A; Richards, MJ | 1 |
| Abeck, D; Ballard, RC | 1 |
| Abdollahi, K; Knapp, TP; Lee, J; Patzakis, MJ; Reisch, RB; Seipel, PR | 1 |
| Elkhaïli, H; Jehl, F; Kamili, N; Linger, L; Monteil, H; Pompei, D | 1 |
| Conte, JE; Duncan, S; Golden, J; Lin, E; McKenna, E; Zurlinden, E | 1 |
| Bosso, JA; Burgess, DS; Manduru, M; White, RL | 1 |
| Ashford, K; Crowe, M; Ispahani, P | 1 |
| Gould, IM; Hobson, RP; MacKenzie, FM | 1 |
| Dalla Costa, T; Derendorf, H | 1 |
| Akalin, E; Arikan, S; Auckenthaler, R; Bergan, T; Dornbusch, K; Howard, AJ; Hryniewicz, W; Jones, RN; Koupari, G; Legakis, NJ; McLaughlin, J; Ozkuyumcu, C; Percival, A; Phillips, I; Reeves, D; Spencer, R; Warren, RE; Williams, JD; Yeo, SF | 1 |
| Chen, YS; Cheng, DL; Liu, YC; Wang, JH; Wann, SR; Yen, MY | 1 |
| Bell-Dixon, C; Itokazu, GS; Kahan, FM; Quinn, JP; Weinstein, RA | 1 |
| Adenis, JP; Badrinath, SS; Caldwell, DR; Eiferman, RA; Hyndiuk, RA; Katz, HR; Klauss, V; Reddy, MK; Rosenwasser, GO; Santos, CI | 1 |
| Knapp, CC; Ludwig, MD; Pohlman, JK; Washington, JA | 1 |
| Nishino, T; Otsuki, M | 1 |
| Durrani, AB; Rab, SM | 1 |
| Martinez-Martinez, L; Pascual, A; Perea, EJ; Rodriguez, G; Suárez, AI | 1 |
| Fink, U; Reiser, M; Sauter, G; Seemann, M; Wintersperger, BJ | 1 |
| Garcia, R; Raad, I | 1 |
| Bierkens, AF; de la Rosette, JJ; Debruyne, FM; Doesburg, W; Ezz el Din, KE; Hendrikx, AJ; Horrevorts, A | 1 |
| Ban, Y; Deguchi, T; Fukuoka, A; Ishihara, S; Kanematsu, E; Kawada, Y; Nakano, M; Nishino, Y; Ozeki, S; Yasuda, M | 1 |
| Cartwright, K; Dooley, J; Fairclough, P; Mani, V; Oakley, C; Swarbrick, E | 1 |
| Hori, R; Hoshino, E; Kohno, S | 1 |
| Quentin, C; Tessier, F | 1 |
| Feeney, R; Jones, EM; Kirkpatrick, BL; MacGowan, AP; Reeves, DS | 1 |
| Collins, JJ; Giguere, GC; Hook, EW; McCormack, WM; Mussari, KL; Rompalo, A; Schwebke, JR; Thorpe, EM | 1 |
| Iaconis, JP; Nadler, HL; Pitkin, DH; Sheikh, W | 1 |
| Ballow, CH; Forrest, A; Hyatt, JM; Luzier, AB; Schentag, JJ | 1 |
| Amato, GM; Giuffrè, M; Manfrè, L; Morello, A | 1 |
| Gorby, GL; Phanucharas, JP | 1 |
| Cormio, L; La Forgia, D; La Forgia, P; Ruutu, M; Siitonen, A | 1 |
| Dotters, DJ; James, AH; Katz, VL; Rogers, RG | 1 |
| Fraser, V; Kollef, MH; Murphy, D; Pasque, C; Sharpless, L; Vlasnik, J | 1 |
| Constantoulaki, S; Paniara, O; Platsouka, E; Zissis, NP | 1 |
| Huovinen, P; Jahkola, M; Järvinen, H; Liimatainen, O; Nissinen, A | 1 |
| Degener, JE; Kosterink, JG; Mulder, JG | 1 |
| Dryden, M; Page, A; Sampson, M; Samuel, W; Shepherd, H | 1 |
| Hellström, P; Kontturi, M; Leppilahti, M; Lukkarinen, O; Tammela, T | 1 |
| Bhutta, ZA | 1 |
| Belousov, IuB; Efremenkova, OV; Komarova, VP; Sokolov, AV; Tishchenkova, IF | 1 |
| Goldsmith, CE; Moore, JE; Murphy, PG | 1 |
| Atkins, BL; Gottlieb, T | 1 |
| Eltahawy, AT | 1 |
| Echols, RM; Heyd, A; Klein, GL; Whalen, E | 1 |
| Alveyn, CG; Davis, AJ; Kolios, G; Robertson, DA | 1 |
| Felmingham, D; Grüneberg, RN; Harding, I; Robbins, MJ; Shrimpton, S; Tesfaslasie, Y | 1 |
| Dessens, M; van de Laar, MJ; van Duynhoven, YT; van Klingeren, B; van Santen, M | 1 |
| Joseph, EM; Sperling, NM | 1 |
| Preston, DA; Turik, M | 1 |
| Amyes, SG; Cakir, N; Gülay, Z; Mehr, MA; Yüce, A; Yulug, N | 1 |
| Abo Rahmy, E | 1 |
| Andremont, A; Guy, H; Marie, JP; Pico, JL; Richet, H; Vekhoff, A | 1 |
| Casey, AT; Davies, AP; Hart, AJ; Stannard, AJ; Thompson, P | 1 |
| Bernhardt, H; Knoke, M; Schulz, K; Zimmermann, K | 1 |
| Brown, MR; Bühler, T; Desai, M; Weller, PH | 1 |
| Gabriel, V; Garbino, J; Harbarth, S; Lew, D; Pittet, D | 1 |
| Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
| Jin, S; Wu, Q; Zhang, F | 1 |
| Cisterna, R; Fresnadillo, MJ; García-Rodríguez, JA; Gobernado, M; Martín, R; Perea, E; Picazo, J | 1 |
| Aneiro, L; Chodosh, S; Drehobl, M; Farkas, S; Kowalsky, S; McCarty, J; Shan, M; Tosiello, R | 1 |
| Cavallo, JD; Fabre, R; Martet, G; Nicolas, P | 1 |
| Peters, G; Schumacher-Perdreau, F | 1 |
| Ahmed, A; Ahmed, QT; Hafiz, S; Majeed, H; Syed, S | 1 |
| Belousov, IuB; Efremenkova, OV; Komarova, VP | 1 |
| Ho, SW; Hsueh, PR; Jan, IS; Luh, KT; Teng, LJ | 1 |
| Herford, T; Hill, DA; Parratt, D | 1 |
| Brase, R; Heimesaat, M; Kljucar, S; Manhold, C; Timm, J; von Pritzbuer, E; von Rolbicki, U | 1 |
| Caron, F | 1 |
| Blondeau, JM; Borsos, S; Misfeldt, C; Suter, ME | 1 |
| Hamilton-Miller, JM; Shah, S | 1 |
| Barkay, A; Block, C; Keller, N; Leitner, L; Leventhal, A; Shehab, S | 1 |
| Berger, D; Heinemann, M; Möricke, A; Seidelmann, M; Trautmann, M; Zick, R | 1 |
| Bonvin, P; Dons-Jensen, H; Ejlertsen, T | 1 |
| Blondeau, JM; Borsos, S; Suter, M | 1 |
| Ballow, CH; Forrest, A; Highet, VS; Schentag, JJ | 1 |
| Cox, CE; Echols, RM; Klimberg, IW; Kowalsky, SF; Malek, GH; Patterson, AL; Whalen, E | 1 |
| Barbabietola, G; Bucaneve, G; Cavicchi, F; Del Favero, A; Gentile, G; Iori, AP; Landonio, G; Martino, P; Menichetti, F; Micozzi, A; Minotti, V | 1 |
| Po, AL; Scott, EM; Tariq, VN; Wu, YL | 1 |
| Appelbaum, PC; Hoellman, DB; Jacobs, MR; Lin, G | 1 |
| Mayer, I; Nagy, E | 2 |
| Chan, KW; Culbert, SJ; Danielson, M; Jeha, SS; Kuttesch, JF; Mullen, CA; Petropoulos, D; Roberts, WM; Rolston, KV; Rytting, M; Zipf, T | 1 |
| Edouard, AR; Incagnoli, P; Jacolot, A; Mimoz, O; Petitjean, O; Samii, K; Tod, M | 1 |
| Karski, J; Karski, M; Misztal, M; Paluszkiewicz, P | 1 |
| Filka, J; Huttova, M; Kralinsky, K; Krcmery, V; Sagat, T; Tuharsky, J | 1 |
| Bergh, K; Løseth, K; Persen, L; Witsø, E | 1 |
| Cannon, JG; Johnston, DM | 1 |
| Berger, D; Heinemann, M; Lorenz, I; Möricke, A; Schneider, M; Seidelmann, M; Steinbach, G; Trautmann, M | 1 |
| Eliasson, I; Erlandsson, CM; Hanberger, H; Hoffmann, M; Isaksson, B; Lindgren, S; Nilsson, LE; Sörén, L; Walther, SM | 1 |
| Doré, P; Fauchère, JL; Ferrand, E; Grollier, G; Hira, M; Robert, R | 1 |
| Antabli, BA; Bross, P; Siegel, RS; Small, CD; Tabbara, IA | 1 |
| Campos, MC; Dantas, LS; Ginani, VC; Petrilli, AS; Seber, A; Tanaka, C | 1 |
| Bolander, ME; Hanssen, AD; Huddleston, PM; Patel, R; Rouse, MS; Steckelberg, JM | 1 |
| Jiang, L; Peng, Q; Yao, Y | 1 |
| Bales, GT; Christiano, AP; Gerber, GS; Hollowell, CM; Kim, H; Kim, J; Patel, R | 1 |
| Desta, TD; Inciardi, JF; Lam, K; Leung, JW; Libby, ED; Liu, YL | 1 |
| Chiba, A; Harada, S; Hasegawa, M; Kaneko, A; Kobayashi, I; Koyama, H; Matsuzaki, K; Omika, K; Sasaki, J; Sato, Y | 1 |
| Donovan, KD; Gage, JW; Shapiro, MA | 1 |
| Dicker, AP; Figura, AT; Gomella, LG; Strup, SE; Valicenti, RK; Waterman, FM | 1 |
| Au, T; Breen, D; Reiss-Levy, E; Schonell, M | 1 |
| Dominik, J; Hejzlar, M; Kubícek, J; Lonská, V; Lonský, V; Mand'ák, J; Marsíková, M; Pozlerová, E; Snítilová, M | 1 |
| Barfod, S | 1 |
| de Louvois, J; Price, EH; Workman, MR | 1 |
| Butkevich, OM; Vinogradova, TL | 1 |
| Antoniadou, A; Bassaris, HP; Busch, W; Giamarellou, H; Grouzi, E; Petrikkos, G; Voulgarelis, M; Zoumbos, N | 1 |
| Dagan, R; Janco, J; Leibovitz, E; Piglansky, L; Press, J; Reinhart, H; Yagupsky, P; Yaniv, I | 1 |
| Boylan, CJ; Contag, PR; Foley, JW; Iversen, PW; Jenkins, DE; LeTourneau, DL; McMillian, CL; Parr, TR; Rocchetta, HL | 1 |
| Duch, JM; Yee, J | 1 |
| Dragsted, UB; Pedersen, P | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| Adinolfi, LE; Andreana, A; Ragone, E; Sarnataro, G; Tripodi, MF; Utili, R | 1 |
| Phantumchinda, K; Suankratay, C; Tachawiboonsak, W; Wilde, H | 1 |
| Domínguez, L; Fernández-Garayzábal, JF; Latre, MV; Moreno, MA; Rodríguez, AA; Vela, AI | 1 |
| Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P | 1 |
| Aplasca De Los Reyes, MR; Dallabetta, G; Holmes, KK; Klausner, JD; Manalastas, R; Pato-Mesola, V; Tuazon, CU; Whittington, WL; Wi, T | 1 |
| Casado, E; Giménez, M; Olivé, A; Ortiz-Santamaria, V | 1 |
| Dillon, JA; Li, H; Prabhakar, P; Ruben, M; Sealy, J | 1 |
| Basak, M; Bhattacharya, SK; Datta, S; De, A; Dutta, P; Mitra, U; Roy, K; Saha, MR | 1 |
| Amorena, B; García-Alvarez, F; Gracia, E; Laclériga, A; Leiva, J; Monzón, M; Oteiza, C | 1 |
| Barnhill, MA; Hendrix, DV; Ward, DA | 1 |
| SoRelle, R | 1 |
| Aggelis, P; Dalamaga, A; Ferti, A; Garzonis, P; Kanavaki, S; Kapralos, C; Karambela, S; Makarona, M; Roussos, A; Stambori, M | 1 |
| Brown, A; Camara, B; Castor, D; Furlonge, C; Jolly, PE; Prabhakar, P; Rao, A; Weiss, H | 1 |
| Higashiyama, Y; Hirakata, Y; Kadota, JI; Kakeya, H; Kaneko, Y; Kohno, S; Kuroki, M; Miyazaki, Y; Ohi, H; Tomono, K; Yanagihara, K | 1 |
| Bhattacharya, SK; Chatterjee, MK; De, A; Dutta, P; Dutta, S; Mitra, U | 1 |
| Jung, R; Messick, CR; Pendland, SL | 1 |
| Abraham, G; Arthur, P; Gouthaman, S; Manjunath, S; Mathew, M; Sekhar, U | 1 |
| Blandino, G; Caccamo, F; Milazzo, I; Musumeci, R; Nicoletti, G; Speciale, A | 1 |
| Calvo, A; García, R; Gómez-Lus, ML; Leturia, A; Sevillano, D; Valero, E | 1 |
| Paganini, H; Zubizarreta, P | 1 |
| Baliga, S; Prabha Adhikari, MR | 1 |
| Banky, JP; Ostergaard, L; Spelman, D | 1 |
| Beguin, Y; Debouge, MH; Fillet, G; Frère, P; Hermanne, JP | 1 |
| Henneberg, JP; Neubert, U | 1 |
| Barkham, T; Bellamy, R | 1 |
| Caulin, C; Fiszbin, M; Gravisse, J; Hanau-Berçot, B; Raskine, L; Rottman, M; Sanson-Le Pors, MJ | 1 |
| Harada, T; Ito, Y; Iwai, S; Iwanaga, H; Kato, K; Nakagawa, Y; Sato, T; Takayama, T | 1 |
| Jones, RN; Mutnick, AH; Turner, PJ | 1 |
| Andresen, SW; Avery, RK; Bernhard, L; Bolwell, BJ; Goormastic, M; Kalaycio, ME; Kuczkowski, E; Longworth, DL; Mossad, SB; Ostendorf, H; Pohlman, BL; Sobecks, RM; Wise, K | 1 |
| Hiltunen-Back, E; Reunala, T | 1 |
| Burgess, DS; Nathisuwan, S | 1 |
| Hasegawa, M; Kobayashi, I; Matsuzaki, K; Sato, Y; Shikano, M; Watabe, E; Yoshimori, K | 1 |
| Blanco, G; de Mier, C; Famiglietti, A; Juárez, J; Pugliese, L; Rodríguez, CH; Vay, C | 1 |
| Kovalenko, AN; Lobzin, IuV | 1 |
| Bernatoniene, G; Kaltenis, P; Murauskaite, G | 1 |
| Mayayo Dehesa, T; Navas Elorza, E; Quereda Rodríguez-Navarro, C; Rodríguez-Patrón Rodríguez, R | 1 |
| Jones, RN; Rhomberg, PR | 1 |
| Derevianko, II | 1 |
| Kinzig-Schippers, M; Naber, KG; Onda, H; Sörgel, F; Wagenlehner, FM; Wydra, S | 1 |
| Aoki, S; Gotoh, N; Hirakata, Y; Kamihira, S; Kohno, S; Kondoh, A; Miyazaki, Y; Tomono, K; Yamada, Y; Yanagihara, K | 1 |
| Chen, TP; Chen, YH; Lu, PL; Peng, CF; Tsai, JJ | 1 |
| Bassaris, HP; Drosou, E; Gogos, CA; Lekkou, A; Marangos, MN; Skoutelis, A; Starakis, I | 1 |
| Bonten, MJ; Florijn, A; Fluit, AC; Nijssen, S; Schmitz, FJ; Verhoef, J | 1 |
| Choe, KW; Kang, CI; Kim, EC; Kim, HB; Kim, SH; Lee, KD; Oh, MD; Park, WB | 1 |
| Shmelev, EI | 1 |
| Conway, SP; Denton, M; Nadesalingam, K | 1 |
| de Ciman, R; Gross, U; Zimmermann, O | 1 |
| Tumah, H | 1 |
| Alyaseen, SA; Patel, R; Piper, KE; Rouse, MS; Steckelberg, JM | 1 |
| Chowta, MN; Chowta, NK | 1 |
| Chiou, CS; Lauderdale, TL; Tsai, SH; Wu, JJ; Yan, JJ | 1 |
| Alvarez, A; Baquero, F; Cantón, R; Cobos, N; de Gracia, J; García-Quetglas, E; Gartner, S; Honorato, J; Oliver, A; Salcedo, A | 1 |
| Kuti, JL; Nicolau, DP; Sun, HK | 1 |
| Hashikita, G; Kawakami, S; Kobayashi, S; Maesaki, S; Nagasawa, M; Okabe, T; Sasaki, K; Shibuya, S; Suzuki, N; Takayama, S; Uchida, T; Watanabe, M; Yamaguchi, T | 1 |
| Adukauskiene, D; Dudzevicius, V; Ryskus, L; Sakalauskas, R; Vitkauskiene, A | 1 |
| Decorby, MR; Hoban, DJ; Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
| Paterson, DL | 1 |
| Legout, L; Migaud, H; Mouton, Y; Rosele, B; Roussel-Delvalez, M; Savage, C; Senneville, E; Stern, R; Yazdanpanah, Y | 1 |
| Kawano, F; Koga, S; Matsuoka, H; Okamura, S; Shibata, K; Shirahashi, A; Suzushima, H; Tamura, K; Tsukamoto, A; Uozumi, K; Yamashita, K | 1 |
| Bedenic, B; Bubonja, M; Budimir, A; Topic, M | 1 |
| Bang, JW; Choe, KW; Kang, CI; Kim, EC; Kim, HB; Kim, NJ; Kim, SH; Oh, MD | 1 |
| Konkoly-Thege, M; Kuti, JL; Ludwig, E; Nicolau, DP | 1 |
| McElhinney, J; Palmer, HM; Young, H | 1 |
| Bokaei, S; Etemadi, G; Feizabadi, MM; Rahmati, M; Shabanpoor, S; Yadegarinia, D | 1 |
| Patel, SM; Saravolatz, LD | 1 |
| Alp, E; Aygen, B; Metan, G; Sumerkan, B | 1 |
| Li, JT; Markus, P; Matesic, D; Park, M | 1 |
| Arnesi, N; Bencomo, B; Bermejo, J; Borda, N; Lesnaberes, P; Notario, R | 1 |
| Farkas, A; Papp, M; Tornai, I; Udvardy, M | 1 |
| Elsa, V; María, A; Nieves, B; Ruíz, J; Ruiz, M; Salazar De Vegas, EZ; Vila, J | 1 |
| Aggarwal, P; Capoor, MR; Deb, M; Nair, D | 1 |
| Blot, SI; Decruyenaere, JM; Depuydt, PO; Vandijck, DM | 1 |
| Cho, YH; Ha, US; Han, CH; Kim, CS; Kim, ME; Lee, SD; Shim, BS | 1 |
| Beckius, ML; Fraser, SL; Galloway, RL; Griffith, ME; Hospenthal, DR; Mende, K; Miller, RS; Murray, CK; Pimentel, G; Ressner, RA | 1 |
| Blunt, MC; Liebowitz, LD | 1 |
| Juan, C; Maciá, MD; Mena, A; Mulet, X; Oliver, A; Pérez, JL | 1 |
| Aillet, S; Bourdais, L; Heusse, JL; Schoentgen, C; Watier, E | 1 |
| Eames, T; Grabein, B; Kroth, J; Wollenberg, A | 1 |
| Lee, HJ; Lee, KM; Suh, JT; Yang, HY | 1 |
| Doumith, M; Ellington, MJ; Hornsey, M; Hudson, S; Livermore, DM; Woodford, N | 1 |
| Appelbaum, PC; Ednie, LM; Lin, G; Pankuch, GA | 1 |
| Falagas, ME; Gkegkes, ID; Kastoris, AC; Rafailidis, PI; Vouloumanou, EK | 1 |
| Adams, C; Clair, J; Mac Aogáin, M; Mooij, MJ; O'Gara, F | 1 |
| Ayala, JA; Bado, I; Bazet, C; Cordeiro, NF; García-Fulgueiras, V; Gutkind, G; Robino, L; Seija, V; Vignoli, R | 1 |
| Huang, CT; Li, LH; Li, SY; Liao, MH; Lin, KY; Wong, WW; Yen, MY | 1 |
| Boileau, P; Coquery, S; Guibert, M; Traoré, P; Zupan-Simunek, V | 1 |
| Willcox, MD | 1 |
| Caldera, J; Calvo, A; Figuera, M; Gómez, M; Guevara, RN; Khalil, R; Landaeta, ME; Morón, M; Nuñez, MJ; Palavecino, S; Redondo, MC; Ríos, H; Rivera, R; Vitelli, J | 1 |
| Blasi, F; Butler, CC; Coenen, S; Goossens, H; Hood, K; Kelly, MJ; Little, P; Nuttall, J; Schaberg, T; Torres, A; Verheij, T; Wood, J | 1 |
| Abele-Horn, M; Frosch, M; Müller, S; Tappe, D; Valenza, G | 1 |
| Fukui, H | 1 |
| Cho, YK; Jeon, WK; Kim, BI; Kim, DJ; Kim, HJ; Kim, HS; Park, DI; Park, JH; Sohn, CI | 1 |
| Barshikar, S; Baylor, AE; Dolman, HS; Glowniak, J; Hong, K; Lavery, T; Nailor, M; Singla, R; Stassinopoulus, J; Tyburski, JG; Wilson, RF; Zimmerman, LH | 1 |
| Karpov, AV; Kondratenok, VA; Kovalenko, AN; Murachev, AA; Shishkin, MK; Tokmakov, VS; Volzhanin, VM; Zhdanov, KV | 1 |
| Chen, TY; Lee, YT; Liu, KS; Teng, YH; Tsao, SM; Tsui, TL; Wang, YL | 1 |
| Bhattacharya, SS; Choudhury, BK; Das, U | 1 |
| Bicalho, ML; Bicalho, RC; Caixeta, LS; Machado, VS; Pereira, RV; Santos, TM | 1 |
| Cui, S; Hu, C; Jin, S; Li, J; Lin, L; Luo, Y; Ma, Y; Ran, L; Zhang, W | 1 |
| Fuentes, JM; Mullins, ME; Roe, JL | 1 |
| Baier, M; Bruns, T; Pfister, W; Pletz, MW; Reuken, PA; Stallmach, A | 1 |
| Bogomolova, NS; Bol'shakov, LV; Kuznetsova, SM; Parshin, VD; Vishnevskaia, GA | 1 |
| Coutinho, AS; de Morais, OO; de Oliveira Carneiro da Motta, J; Gomes, CM | 1 |
| Aziz, MN; Desa, MN; Idris, SN; Taib, NM | 1 |
| Adelson, ME; Balashov, S; Gygax, SE; Mordechai, E | 1 |
| Atsuta, Y; Emi, N; Inamoto, Y; Ishikawa, Y; Nagai, H; Naoe, T; Ozawa, Y; Ozeki, K; Suzuki, R; Terakura, S; Yanada, M; Yasuda, T | 1 |
| Akashi, K; Chong, Y; Ito, Y; Kamimura, T; Miyamoto, T; Shimoda, S; Shimono, N; Yakushiji, H | 1 |
| Davies, RH; Horton, RA; Lemma, FL; Mueller-Doblies, D; Randall, LP; Teale, CJ | 1 |
| Carrique-Mas, JJ; Clouting, C; Davies, RH; Gosling, RJ; Jones, EM; Snow, LC | 1 |
| de Melo Oliveira, MD; Hauser, P; Kovari, H; Läuchli, S; Meyer, J; Weber, R; Zbinden, R | 1 |
| Endimiani, A; Furrer, H; Guilarte, YN; Hauser, C; Hirzberger, L; Lupo, A; Selvini, S; Tinguely, R | 1 |
| De Graef, E; de Jong, A; Haesebrouck, F; Ludwig, C; Smet, A; Stephan, B; Vanrobaeys, M | 1 |
| Baek, JY; Cho, SY; Chung, DR; Kang, CI; Kim, J; Kim, SH; Ko, KS; Peck, KR; Song, JH | 1 |
| Avutu, V; Cao, X; Flynn, PM; Gaur, AH; Hayden, RT; Howard, SC; Inaba, H; Marszal, LN; Pounds, SB; Pui, CH; Ribeiro, RC; Rubnitz, JE | 1 |
| Covens, L; Echahidi, F; François, K; Piérard, D; Pipeleers, L; Wybo, I; Yusuf, E | 1 |
| Chu, X; Guo, YY; Liu, QZ; Shen, LM; Wang, J; Zhang, CL | 1 |
| Mugnai, G; Pesarini, G; Vassanelli, C | 1 |
| Balmat, RP; Saum, LM | 1 |
| Cheong, HJ; Cho, YK; Choi, TY; Chung, MH; Kang, JO; Ki, M; Kim, J; Kim, SJ; Kim, Y; Kwon, KT; Lee, H; Lee, JS; Lim, SK; Pai, H; Park, DW; Ryu, SY; Seo, MR; Wie, SH | 1 |
| Frey, L; Maier, B; Suhr, A; Teupser, D; Vogeser, M; Zander, J; Zoller, M | 1 |
| Chisholm, SA; Cole, MJ; Hoffmann, S; Ison, CA; Spiteri, G; Unemo, M; Van de Laar, M | 1 |
| Arakawa, Y; Jin, W; Kimura, K; Nagasaka, Y; Notake, S; Wachino, J; Yamada, K; Yanagisawa, H | 1 |
| Chavada, R; Howlin, K; Mac, K; Paull, S; Wong, J | 1 |
| Dvornik, IA; Nepomnyashchiy, VV; Shakalova, EA; Tamm, TI | 1 |
| Bonura, C; Di Noto, AM; Ghodousi, A; Mammina, C | 1 |
| Chia, JH; Hsu, PC; Kuo, AJ; Lee, CH; Lee, MH; Su, TY; Ye, JJ | 1 |
| Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F | 1 |
| Aracil-García, B; Campos, J; Cuevas-Lobato, Ó; Fernández-Romero, S; Lara-Fuella, N; Oteo-Iglesias, J; Pérez-Grajera, I; Pérez-Vázquez, M | 1 |
| Ignatius, R; Mertes, T; Regnath, T | 1 |
| Fujii, R; Ishihara, K; Narita, M; Okuda, K; Shibahara, T; Takano, N | 1 |
| Lee, DG; Lee, SH; Lee, Y; Yoo, KH | 1 |
| Chang, FY; Chang, SC; Chen, YS; Chuang, YC; Fung, CP; Huang, IW; Lai, JF; Lauderdale, TL; Lin, WP; Shiau, YR; Tan, MC; Wang, HY; Wang, JT | 1 |
| Al-Agamy, MH; Courvalin, P; El-Mahdy, TS; Jeannot, K; Kattan, W; Plésiat, P; Shibl, AM | 1 |
| Biglari, S; Hanafiah, A; Lopes, BS; Mohd Puzi, S; Rahman, M; Ramli, R | 1 |
| Hong, E; Milenkov, M; Paranhos-Baccalà, G; Raberahona, M; Rakoto-Andrianarivelo, M; Rakotomahefa Narison, ML; Rakotovao, L; Ranaivo Rabetokotany, F; Randria, MJD; Rasoanandrasana, S; Taha, MK | 1 |
| Allan-Blitz, LT; Klausner, JD | 1 |
| Davies, DA; Greba, Q; Howland, JG; Hurtubise, JL | 1 |
| Jiang, FX; Lan, Q; Le, WJ; Su, XH | 1 |
| Arthanareeswaran, VKA; Bálint, P; Dobák, A; Köves, B; Magyar, A; Nagy, K; Tenke, P; Wagenlehner, F | 1 |
| Maxson, T; Minogue, TD; Taylor-Howell, CL | 1 |
| Feicht, S; Finney, S; Habing, G; Hutchinson, H; Masterson, M; Muñoz-Vargas, L | 1 |
| Goodlet, KJ; Nailor, MD; Nicolau, DP | 1 |
| Gavin, HE; Satchell, KJF; Trinh, SA | 1 |
| Demczuk, W; Haldane, D; Hoang, L; Labbé, AC; Lefebvre, B; Martin, I; Mulvey, MR; Naidu, P; Peterson, SW; Wylie, J | 1 |
| Bischoff, S; Ebert, M; Gerigk, M; Vogelmann, R; Walter, T | 1 |
| Abill, K; Boru, WG; Galgallo, DA; Ransom, J; Roka, ZG | 1 |
| Manoharan, N; Maruthupandy, M; Rajivgandhi, G | 1 |
| Adebajo, S; Ake, J; Akintunde, A; Anzick, S; Baral, SD; Barbian, K; Charurat, ME; Crowell, TA; Eluwa, G; Gaydos, CA; Hardick, J; Ivo, A; Lombardi, K; Njab, J; Nowak, RG; Odeyemi, S; Quinn, TC | 1 |
| Cattrall, JWS; Kirby, A; Robinson, AV | 1 |
| Ejaz, A; Ejaz, H; Javed, H; Saleem, R; Younas, S; Zafar, A | 1 |
| Nariya, H; Shimamoto, T; Soliman, AM | 1 |
| Calado, J; Campos, MJ; Castro, R; Lopes, Â; Pereira, F; Rocha, M | 1 |
| Béchet, S; Caeymaex, L; Cohen, R; Lévy, C; Ouldali, N; Tauzin, M | 1 |
| Funaishi, K; Hattori, N; Katsutani, S; Kawamoto, K; Matsumoto, N; Matsumoto, Y; Ohashi, N; Taniwaki, M; Yamasaki, M | 1 |
| Armstrong, A; Clarke, TB; Edwards, AM; Evans, LE; Krishna, A; Ma, Y; Marshall, DC; Spencer, J; Tooke, CL; Webb, TE | 1 |
| Truong, WR; Won, KJ; Yamaki, J | 1 |
| Campisciano, G; Colli, C; Comar, M; Corich, L; De Seta, F; Favero, B; Monasta, L; Petix, V; Zanotta, N | 1 |
| Darboe, KS; Jang, HC; Jung, SI; Kang, SJ; Kim, SE; Kim, UJ; Oh, TH; Park, KH; Shin, HY; Shin, SU | 1 |
| Alves, BG; de Magalhães Rodrigues Martins, CM; Dos Santos, MV; Feckinghaus, MA; Monteiro, CP; Paranhos, LG; Pinheiro, ESC | 1 |
| Boulanger, B; Cizeau, F; Decousser, JW; Ducellier, D; Fourreau, F; Mercier-Darty, M; Mongardon, N; Podglajen, I; Potron, A; Royer, G | 1 |
| Awad, AR; Elawady, BA; ElFeky, DS; Elshobaky, MA | 1 |
| Epps, KL; Epps, QJ; Young, DC; Zobell, JT | 1 |
| Amicizia, D; Iovine, M; Lai, PL; Lecini, E; Marchini, F; Micale, RT; Panatto, D; Pennati, BM; Zangrillo, F | 1 |
| Bertrand, X; Bouxom, H; Gbaguidi-Haore, H; Jeanvoine, A; Leroy, J; Slekovec, C | 1 |
| Beaussac, M; Coton, T; Deniel, C; Javelle, E; Luciano, L; Savini, H; Simon, F | 1 |
| Dong, N; Du, X; Jia, L; Li, Y; Liang, B; Liu, H; Ma, H; Qiu, S; Song, H; Sun, Y; Wang, J; Wu, F; Xia, S; Yang, C; Yang, X; Zhao, J | 1 |
| Alexander, D; Allen, V; Barairo, N; Demczuk, W; Hatchette, TF; Hoang, L; Lefebvre, B; Martin, I; Mulvey, MR; Naidu, P; Peterson, SW; Tomas, K; Trubnikov, M; Wong, T | 1 |
| Sivashanmugam, K; Srivastava, P | 1 |
| Biek, D; Halasohoris, SA; Hannah, B; Lembirik, S; Lemmon, MM; Panchal, RG; Pysz, LM; Scarff, JM; Zumbrun, SD | 1 |
| Gratrix, J; Martin, I; Mulvey, M; Naidu, P; Pilkie, D; Prasad, E; Sawatzky, P; Singh, A; Smyczek, PA; Wong, T | 1 |
| Abaza, M; Aboubakr, M; Awad, D; Edris, S; Fouad, M; Hamad, A; Hussein, A; Nabil, M; Ramadan, H; Sabeq, I; Shama, S | 1 |
| Cuadros, J; Galicia, P; Górgolas, M; Linares, M; Miguel-Benito, A; Pérez García, F; Ramos-Rincón, JM | 1 |
| Bandić-Pavlović, D; Barišić, I; Beader, N; Bedenić, B; Frančula-Zaninović, S; Krilanović, M; Pešorda, L; Schoenthaler, S; Veir, Z | 1 |
| Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N | 1 |
| Abdullah, S; Mohsin, M; Muhammad, F; Rahman, SU | 1 |
| Chan, EW; Chen, S; Xu, Y; Ye, L; Zheng, Z | 1 |
21 review(s) available for cephalosporin c and ciprofloxacin
| Article | Year |
|---|---|
Approach to therapy of respiratory infections in the critical care setting.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Humans; Intensive Care Units; Metronidazole; Pneumonia | 1990 |
New antibiotics: areas of appropriate use.
Topics: Anti-Bacterial Agents; Aztreonam; Bacterial Infections; beta-Lactamase Inhibitors; Cephalosporins; Ciprofloxacin; Enoxacin; Humans; Imipenem; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Thienamycins | 1987 |
Infections of implantable cardioverter defibrillators: approach to management.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cephalosporins; Ciprofloxacin; Defibrillators, Implantable; Escherichia coli; Humans; Male; Middle Aged; Penicillins; Retrospective Studies; Risk Factors; Serratia marcescens; Staphylococcal Infections; Staphylococcus aureus; Streptococcus agalactiae; Surgical Wound Infection; Ventricular Fibrillation | 1993 |
Skull osteomyelitis due to Salmonella species: two case reports and review.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefotaxime; Cephalosporins; Child; Ciprofloxacin; Female; Humans; Magnetic Resonance Imaging; Middle Aged; Osteomyelitis; Salmonella Infections; Salmonella typhimurium; Skull; Tomography, X-Ray Computed | 1996 |
Chancroid.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Cephalosporins; Chancroid; Ciprofloxacin; Erythromycin; HIV Infections; Humans | 1996 |
Comparison of intravenous and oral antibiotic therapy in the treatment of fractures caused by low-velocity gunshots. A prospective, randomized study of infection rates.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Cephapirin; Ciprofloxacin; Drug Therapy, Combination; Female; Fractures, Bone; Gentamicins; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Wound Infection; Wounds, Gunshot | 1996 |
Clinical features and antibiotic treatment of septic arthritis and osteomyelitis due to Yersinia enterocolitica.
Topics: Administration, Oral; Adolescent; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Infectious; Cephalosporins; Ciprofloxacin; Female; Gentamicins; Humans; Male; Middle Aged; Osteomyelitis; Yersinia enterocolitica; Yersinia Infections | 1996 |
[Current role of aminoglycosides in the treatment of acute pyelonephritis].
Topics: Acute Disease; Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cefadroxil; Cefotaxime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Intravenous; Inpatients; Male; Norfloxacin; Pyelonephritis; Recurrence; Time Factors; Tobramycin; Urinary Tract Infections | 1998 |
Chronic relapsing salmonella osteomyelitis in an immunocompetent patient: case report and literature review.
Topics: Adult; Anti-Infective Agents; Cefazolin; Ceftriaxone; Cephalosporins; Chronic Disease; Ciprofloxacin; Drug Therapy, Combination; Floxacillin; Humans; Immunocompetence; Male; Osteomyelitis; Penicillins; Recurrence; Salmonella; Salmonella Infections; Time Factors | 2002 |
[Changing epidemiological profile and treatment of syphilis and gonorrhea].
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Contact Tracing; Drug Resistance, Bacterial; Female; Finland; Gonorrhea; Humans; Penicillin G Procaine; Pregnancy; Pregnancy Complications, Infectious; Syphilis | 2002 |
[Respiratory fluoroquinolones in the treatment of exacerbations of chronic obstructive lung disease].
Topics: Administration, Oral; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Fluoroquinolones; Humans; Injections, Intravenous; Ofloxacin; Pulmonary Disease, Chronic Obstructive; Risk Factors; Time Factors | 2004 |
Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bronchopneumonia; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cystic Fibrosis; Drug Therapy, Combination; Humans; Inhalation; Injections, Intravenous; Lung Diseases; Pneumonia, Bacterial; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2005 |
Resistance in gram-negative bacteria: enterobacteriaceae.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Carbapenems; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Bacterial; Drug Resistance, Multiple; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacterial Infections; Humans; Klebsiella Infections; Quinolones; Urinary Tract Infections | 2006 |
Monotherapy versus combination therapy.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cellulitis; Cephalosporins; Ciprofloxacin; Diverticulitis; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Humans; Meningitis, Bacterial; Neutropenia; Osteomyelitis; Pneumonia; Staphylococcus aureus; Viridans Streptococci | 2006 |
[Bacterial infections in liver cirrhosis].
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Ascites; Bacteremia; Bacterial Infections; Cefotaxime; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Liver Cirrhosis; Norfloxacin; Peritonitis; Pneumonia, Bacterial; Primary Prevention; Severity of Illness Index; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2007 |
Enteric fever perspective in India: emergence of high-level ciprofloxacin resistance and rising MIC to cephalosporins.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Humans; India; Male; Microbial Sensitivity Tests; Salmonella paratyphi A; Salmonella typhi; Typhoid Fever | 2007 |
Review of resistance of ocular isolates of Pseudomonas aeruginosa and staphylococci from keratitis to ciprofloxacin, gentamicin and cephalosporins.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gentamicins; Humans; Keratitis; Pseudomonas aeruginosa; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus | 2011 |
A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis.
Topics: Acute Disease; Administration, Oral; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Combinations; Humans; Norfloxacin; Pyelonephritis; Randomized Controlled Trials as Topic; Sulfamethizole; Trimethoprim | 2018 |
State of the art in cystic fibrosis pharmacology-Optimization of antimicrobials in the treatment of cystic fibrosis pulmonary exacerbations: I. Anti-methicillin-resistant Staphylococcus aureus (MRSA) antibiotics.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Clindamycin; Cystic Fibrosis; Humans; Linezolid; Lipoglycopeptides; Methicillin; Methicillin-Resistant Staphylococcus aureus; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2020 |
Burden of typhoid fever and cholera: similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas.
Topics: Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Azithromycin; Bicarbonates; Cephalosporins; Cholera; Cholera Vaccines; Ciprofloxacin; Drinking Water; Drug Resistance, Bacterial; Endemic Diseases; Epidemics; Europe; Global Burden of Disease; Glucose; Humans; Idarubicin; Potassium Chloride; Prednisone; Ringer's Lactate; Sanitation; Sodium Chloride; Travel; Travel Medicine; Travel-Related Illness; Typhoid Fever; Typhoid-Paratyphoid Vaccines; Vidarabine | 2019 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever | 2022 |
35 trial(s) available for cephalosporin c and ciprofloxacin
| Article | Year |
|---|---|
Oral ciprofloxacin versus intravenous cefuroxime as prophylaxis against postoperative infection in vascular surgery: a randomised double-blind, prospective multicentre study.
Topics: Administration, Oral; Anti-Infective Agents; Antibiotic Prophylaxis; Binomial Distribution; Cefuroxime; Cephalosporins; Ciprofloxacin; Double-Blind Method; Humans; Infusions, Intravenous; Logistic Models; Prospective Studies; Surgical Wound Infection; Sweden; Vascular Surgical Procedures | 1995 |
Antibiotic prophylaxis for ERCP: a randomized clinical trial comparing ciprofloxacin and cefuroxime in 200 patients at high risk of cholangitis.
Topics: Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Ciprofloxacin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Risk Factors | 1995 |
Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prospective Studies; Prosthesis-Related Infections; Pseudomonas Infections | 1995 |
Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas aeruginosa.
Topics: Adult; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross-Over Studies; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Serum Bactericidal Test | 1995 |
Comparison of intravenous and oral antibiotic therapy in the treatment of fractures caused by low-velocity gunshots. A prospective, randomized study of infection rates.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Cephapirin; Ciprofloxacin; Drug Therapy, Combination; Female; Fractures, Bone; Gentamicins; Humans; Injections, Intravenous; Male; Middle Aged; Prospective Studies; Wound Infection; Wounds, Gunshot | 1996 |
Comparison of ciprofloxacin ophthalmic solution 0.3% to fortified tobramycin-cefazolin in treating bacterial corneal ulcers. Ciprofloxacin Bacterial Keratitis Study Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Cefazolin; Cephalosporins; Child; Ciprofloxacin; Cornea; Corneal Ulcer; Double-Blind Method; Drug Therapy, Combination; Eye Infections, Bacterial; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Tobramycin | 1996 |
The value of antibiotic prophylaxis during extracorporeal shock wave lithotripsy in the prevention of urinary tract infections in patients with urine proven sterile prior to treatment.
Topics: Administration, Oral; Anti-Infective Agents; Antibiotic Prophylaxis; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Intravenous; Lithotripsy; Male; Middle Aged; Prospective Studies; Time Factors; Ureteral Calculi; Urinary Tract Infections | 1997 |
Comparison of single-dose cefuroxime axetil with ciprofloxacin in treatment of uncomplicated gonorrhea caused by penicillinase-producing and non-penicillinase-producing Neisseria gonorrhoeae strains.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefuroxime; Cephalosporins; Cervix Uteri; Ciprofloxacin; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillinase; Treatment Outcome; Urethra | 1996 |
Modeling the response of pneumonia to antimicrobial therapy.
Topics: Anti-Infective Agents; Cefmenoxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Humans; Microbial Sensitivity Tests; Models, Biological; Pneumonia, Bacterial; Predictive Value of Tests; Regression Analysis; Treatment Outcome | 1997 |
Antibiotic prophylaxis in patients with urinary retention undergoing transurethral prostatectomy.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Ceftazidime; Cephalosporins; Ciprofloxacin; Humans; Male; Prospective Studies; Prostatectomy; Treatment Outcome; Urinary Catheterization; Urinary Retention; Urinary Tract Infections | 1997 |
Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
Topics: Acute Disease; Adult; Aged; Analysis of Variance; Anti-Infective Agents; Cefuroxime; Cephalosporins; Chi-Square Distribution; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Prospective Studies; Random Allocation; Sinusitis | 1998 |
Antibiotic prophylaxis for ERCP: a comparison of oral ciprofloxacin with intravenous cephazolin in the prophylaxis of high-risk patients.
Topics: Administration, Oral; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bile; Cefazolin; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Ciprofloxacin; Diarrhea; Escherichia coli; Escherichia coli Infections; Female; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Risk Factors; Sepsis; Streptococcal Infections; Streptococcus; Treatment Outcome; Urticaria | 1998 |
Neutropenic infections: a review of the French Febrile Aplasia Study Group trials in 608 febrile neutropenic patients.
Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Multivariate Analysis; Neutropenia; Opportunistic Infections; Penicillanic Acid; Piperacillin; Tazobactam; Vancomycin | 1998 |
Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
Topics: Acute Disease; Adolescent; Adult; Anti-Infective Agents; Bronchitis; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Consumer Product Safety; Double-Blind Method; Female; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome | 1998 |
[Selection of antibacterial therapy for treatment of infections in elderly patients].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Fluoroquinolones; Humans; Male; Quinolones; Respiratory Tract Infections | 1998 |
Outbreaks of Staphylococcus aureus infections during treatment of late onset pneumonia with ciprofloxacin in a prospective, randomized study.
Topics: Adult; Anti-Infective Agents; APACHE; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Disease Outbreaks; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Intensive Care Units; Pneumonia, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Superinfection | 1998 |
Single-dose oral ciprofloxacin compared with cefotaxime and placebo for prophylaxis during transurethral surgery.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Bacteriuria; Cefotaxime; Cephalosporins; Ciprofloxacin; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos; Prostatectomy | 1999 |
Domiciliary treatment of febrile episodes in cancer patients: a prospective randomized trial comparing oral versus parenteral empirical antibiotic treatment.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Fever; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Neutropenia; Outpatients; Prospective Studies; Treatment Outcome | 1999 |
Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Topics: Adolescent; Ambulatory Care; Antineoplastic Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Humans; Male; Neoplasms; Neutropenia; Prospective Studies; Risk Assessment | 1999 |
[Antibacterial treatment in patients after extended bowel resection with ileo-cecal valve removal--personal experience].
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Diarrhea; Digestive System Surgical Procedures; Drug Therapy, Combination; Humans; Ileocecal Valve; Intestine, Small; Metronidazole; Middle Aged; Postoperative Care; Short Bowel Syndrome; Surgical Wound Infection | 1998 |
Empiric antimicrobial therapy of febrile neutropenic patients undergoing haematopoietic stem cell transplantation.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacterial Infections; Bone Marrow Transplantation; Ceftazidime; Cephalosporins; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia | 1999 |
Oral ciprofloxacin vs. intravenous ceftriaxone administered in an outpatient setting for fever and neutropenia in low-risk pediatric oncology patients: randomized prospective trial.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Anti-Infective Agents; Antineoplastic Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Fever; Humans; Neoplasms; Neutropenia; Prospective Studies; Risk Factors | 2000 |
Double-blind randomized comparison of single-dose ciprofloxacin versus intravenous cefazolin in patients undergoing outpatient endourologic surgery.
Topics: Adult; Anti-Infective Agents; Antibiotic Prophylaxis; Cefazolin; Cephalosporins; Chi-Square Distribution; Ciprofloxacin; Cost-Benefit Analysis; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Postoperative Complications; Treatment Outcome; Urinary Catheterization; Urinary Tract Infections; Urologic Diseases | 2000 |
Changes of the serum antibiotic levels during open heart surgery (ceftazidim, ciprofloxacin, clindamycin).
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Cardiopulmonary Bypass; Ceftazidime; Cephalosporins; Ciprofloxacin; Clindamycin; Coronary Artery Bypass; Humans; Prospective Studies | 2000 |
Monotherapy with intravenous followed by oral high-dose ciprofloxacin versus combination therapy with ceftazidime plus amikacin as initial empiric therapy for granulocytopenic patients with fever.
Topics: Administration, Oral; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Treatment Outcome | 2000 |
Oral ciprofloxacin vs. intramuscular ceftriaxone as empiric treatment of acute invasive diarrhea in children.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Diarrhea; Double-Blind Method; Female; Humans; Infant; Infant, Newborn; Injections, Intramuscular; Male; Prospective Studies | 2000 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome | 2001 |
A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefixime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Neisseria gonorrhoeae; Philippines; Prospective Studies; Sex Work; Treatment Outcome | 2001 |
Concentrations in plasma, urinary excretion, and bactericidal activity of linezolid (600 milligrams) versus those of ciprofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose.
Topics: Acetamides; Adult; Anti-Infective Agents; Area Under Curve; Bacteria; Calibration; Cephalosporins; Ciprofloxacin; Cross-Over Studies; Double-Blind Method; Female; Half-Life; Humans; Hydrogen-Ion Concentration; Linezolid; Male; Oxazolidinones; Quality Control; Serum Bactericidal Test | 2003 |
Comparative effects of ciprofloxacin and ceftazidime on cytokine production in patients with severe sepsis caused by gram-negative bacteria.
Topics: Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cytokines; Female; Gram-Negative Bacterial Infections; Humans; Interleukins; Male; Middle Aged; Sepsis; Treatment Outcome; Tumor Necrosis Factor-alpha | 2004 |
Efficacy of intravenous ciprofloxacin in patients with febrile neutropenia refractory to initial therapy.
Topics: Adult; Aged; Algorithms; Carbapenems; Cefepime; Cephalosporins; Ciprofloxacin; Female; Fever; Hematologic Diseases; Humans; Male; Middle Aged; Neutropenia; Remission Induction; Salvage Therapy; Treatment Failure; Treatment Outcome | 2006 |
Increased intestinal permeability as a predictor of bacterial infections in patients with decompensated liver cirrhosis and hemorrhage.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacterial Infections; Bacterial Translocation; Cephalosporins; Chi-Square Distribution; Ciprofloxacin; Drug Administration Schedule; Esophageal and Gastric Varices; Female; Gastrointestinal Hemorrhage; Humans; Intestines; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Permeability; Predictive Value of Tests; Prospective Studies; Republic of Korea; Risk Assessment; Risk Factors; ROC Curve; Time Factors; Treatment Outcome | 2011 |
Randomized controlled trial comparing ciprofloxacin and cefepime in febrile neutropenic patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Algorithms; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Treatment Outcome; Young Adult | 2013 |
Antibiotic rotation for febrile neutropenic patients with hematological malignancies: clinical significance of antibiotic heterogeneity.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Thienamycins | 2013 |
Noninferiority field trial for evaluation of efficacy of ciprofloxacin associated with internal teat sealant as dry-off protocol.
Topics: Animals; Anti-Bacterial Agents; Bismuth; Brazil; Cattle; Cephalosporins; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Female; Incidence; Lactation; Mammary Glands, Animal; Mastitis, Bovine; Prevalence; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus | 2019 |
293 other study(ies) available for cephalosporin c and ciprofloxacin
| Article | Year |
|---|---|
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Quinolones | 1992 |
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Topics: beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1992 |
Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacin.
Topics: Adult; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Half-Life; Humans; Imipenem; Male; Microbial Sensitivity Tests | 1992 |
Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Outer Membrane Proteins; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cell Membrane Permeability; Cephalosporins; Ciprofloxacin; Coliphages; DNA Replication; DNA, Bacterial; Drug Resistance, Microbial; Escherichia coli; Fleroxacin; Fluoroquinolones; Gene Expression Regulation, Bacterial; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Porins | 1991 |
Dual-action cephalosporins: cephalosporin 3'-quinolone carbamates.
Topics: Animals; Anti-Bacterial Agents; Carbamates; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Escherichia coli; Mice; Pseudomonas aeruginosa; Spectrophotometry, Infrared; Staphylococcus aureus; Streptococcus pneumoniae | 1991 |
Comparative in vitro activity of the new quinolone sparfloxacin (CI-978, AT-4140) against nosocomial gram-negative bloodstream isolates.
Topics: Amikacin; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Cross Infection; Enterobacteriaceae; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Pseudomonas aeruginosa; Sepsis; Tobramycin | 1990 |
Influence of subinhibitory concentrations of cephalosporins on the serum sensitivity of Pseudomonas aeruginosa.
Topics: Amikacin; Blood Bactericidal Activity; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Complement C9; Complement System Proteins; Dose-Response Relationship, Drug; Humans; Imipenem; Lipopolysaccharides; Pseudomonas aeruginosa; Serum Bactericidal Test | 1990 |
Cephalosporin 3'-quinolone esters with a dual mode of action.
Topics: Animals; Anti-Infective Agents; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Ciprofloxacin; Enterobacter; Escherichia coli Infections; Fleroxacin; Fluoroquinolones; Hydrolysis; Mice; Molecular Structure; Pneumococcal Infections; Prodrugs; Quinolones; Rats; Staphylococcus aureus; Structure-Activity Relationship | 1990 |
In vitro antibacterial activity of DR-3355, the S-(-)-isomer of ofloxacin.
Topics: Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Gram-Positive Bacteria; Microbial Sensitivity Tests; Ofloxacin; Topoisomerase II Inhibitors | 1990 |
Comparative in vitro activity of cefpirome and cefepime, two new cephalosporins.
Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests | 1990 |
L-658,310, a new injectable cephalosporin. II. In vitro and in vivo interactions between L-658,310 and various aminoglycosides or ciprofloxacin versus clinical isolates of Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Synergism; Female; Gentamicins; Isoindoles; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1989 |
In vitro activity of fleroxacin and 6 other antimicrobials against Acinetobacter anitratus.
Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Enoxacin; Fleroxacin; Humans; Microbial Sensitivity Tests; Ofloxacin; Tobramycin | 1989 |
Mode of action of the dual-action cephalosporin Ro 23-9424.
Topics: Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Cephalosporins; Ciprofloxacin; DNA Replication; DNA, Bacterial; Enterobacter; Escherichia coli; Fleroxacin; Fluoroquinolones; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus | 1989 |
In vitro activities of a dual-action antibacterial agent, Ro 23-9424, and comparative agents.
Topics: Anti-Bacterial Agents; Bacteria; Cefotaxime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Positive Bacteria; Microbial Sensitivity Tests; Pseudomonas | 1989 |
Comparative determination of minimal inhibitory and bactericidal concentrations of ciprofloxacin, cefotaxime and HR 810 for gram-negative bacteria either sensitive or resistant to ureidopenicillins and/or gentamicin.
Topics: Anti-Bacterial Agents; Cefotaxime; Cefpirome; Cephalosporins; Ciprofloxacin; Gentamicins; Gram-Negative Bacteria; Microbial Sensitivity Tests; Piperacillin; Quinolines | 1985 |
The importance of pharmacodynamics in determining the dosing interval in therapy for experimental pseudomonas endocarditis in the rat.
Topics: Animals; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Gentamicins; Pseudomonas aeruginosa; Pseudomonas Infections; Quinolines; Rats; Rats, Inbred Strains; Time Factors | 1986 |
Antimicrobial susceptibility of group B streptococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Female; Humans; Imipenem; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Quinolines; Streptococcus agalactiae; Thienamycins; Trimethoprim | 1986 |
In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.
Topics: Cefmenoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Erythromycin; Fleroxacin; Haemophilus ducreyi; Humans; Neisseria gonorrhoeae; Penicillins; Spectinomycin; Tetracycline | 1987 |
The activity of the 4 quinolone Ro 23 6240 and the cephalosporins Ro 15 8074 and Ro 19 5247 against penicillin sensitive and resistant gonococci.
Topics: Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Fleroxacin; Neisseria gonorrhoeae; Penicillin Resistance | 1987 |
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
Topics: Amikacin; Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Combinations; Fleroxacin; Mycobacterium; Nontuberculous Mycobacteria; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
Comparative in vitro activity of cefetamet and fleroxacin against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Ceftizoxime; Cephalosporins; Ciprofloxacin; Fleroxacin; Humans | 1987 |
Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones.
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Cell Membrane; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Humans; Norfloxacin; Penicillins; Pseudomonas aeruginosa | 1988 |
Comparative in vitro activities of aztreonam, ciprofloxacin, norfloxacin, ofloxacin, HR 810 (a new cephalosporin), RU28965 (a new macrolide), and other agents against enteropathogens.
Topics: Anti-Bacterial Agents; Aztreonam; Cefpirome; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Leucomycins; Microbial Sensitivity Tests; Nalidixic Acid; Norfloxacin; Ofloxacin; Oxazines; Quinolines | 1985 |
Comparative activities of cefuroxime, amoxicillin-clavulanic acid, ciprofloxacin, enoxacin, and ofloxacin against aerobic and anaerobic bacteria isolated from bite wounds.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Infective Agents; Bacteria; Bites and Stings; Bites, Human; Cats; Cefuroxime; Cephalosporins; Ciprofloxacin; Clavulanic Acids; Dogs; Drug Therapy, Combination; Enoxacin; Humans; Ofloxacin; Wound Infection | 1988 |
Sub-MICs of cefuroxime and ciprofloxacin influence interaction of complement and immunoglobulins with Klebsiella pneumoniae.
Topics: Agglutination Tests; Bacterial Outer Membrane Proteins; Cefuroxime; Cephalosporins; Ciprofloxacin; Complement C3; Complement System Proteins; Culture Media; Drug Interactions; Electrophoresis, Polyacrylamide Gel; Immunoglobulins; Klebsiella pneumoniae; Lipopolysaccharides | 1987 |
In-vitro activity of cefpirome (HR-810), WIN-49375, BMY-28142 and other antibiotics against nosocomially important isolates from cancer patients.
Topics: Anti-Bacterial Agents; Cefepime; Cefpirome; Cephalosporins; Ciprofloxacin; Cross Infection; Fluoroquinolones; Gram-Negative Bacteria; Humans; Imipenem; Microbial Sensitivity Tests; Neoplasms; Quinolines; Thienamycins | 1986 |
Susceptibility of non-fermentative gram-negative bacteria to ciprofloxacin, norfloxacin, amifloxacin, pefloxacin and cefpirome.
Topics: Anti-Infective Agents; Cefpirome; Cephalosporins; Ciprofloxacin; Fluoroquinolones; Gram-Negative Bacteria; Microbial Sensitivity Tests; Norfloxacin; Pefloxacin; Quinolines | 1986 |
Therapeutic efficacy of cefpiramide-ciprofloxacin combination in experimental Pseudomonas infections in neutropenic mice.
Topics: Agranulocytosis; Animals; Cephalosporins; Ciprofloxacin; Cyclophosphamide; Drug Therapy, Combination; Female; Mice; Microbial Sensitivity Tests; Neutropenia; Pseudomonas Infections | 1987 |
Clivus and cervical spinal osteomyelitis with epidural abscess presenting with multiple cranial neuropathies.
Topics: Abscess; Aged; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cranial Fossa, Posterior; Cranial Nerve Diseases; Diagnostic Imaging; Drug Administration Schedule; Drug Therapy, Combination; Epidural Space; Humans; Male; Nerve Compression Syndromes; Neurologic Examination; Osteomyelitis | 1995 |
Antibiotic susceptibility of 206 Haemophilus influenzae isolates collected from children in central Italy.
Topics: Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Chloramphenicol Resistance; Ciprofloxacin; Clavulanic Acids; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Haemophilus Infections; Haemophilus influenzae; Humans; Infant; Italy; Serotyping | 1994 |
Recurrent Salmonella enteritidis sepsis and hepatic tuberculosis.
Topics: Adult; Anti-Infective Agents; Bacteremia; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Recurrence; Salmonella enteritidis; Salmonella Infections; Tuberculosis, Hepatic | 1995 |
A multicentre study of the in-vitro activity of cefotaxime, cefuroxime, ceftazidime, ofloxacin and ciprofloxacin against blood and urinary pathogens.
Topics: Anti-Infective Agents; Bacteremia; Bacteria; Bacteriuria; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Ofloxacin | 1994 |
Antibacterial activity of cefepime in vitro.
Topics: Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospitals, General; Hospitals, Veterans; Humans; Microbial Sensitivity Tests; Taiwan | 1994 |
Enteric fever--a changing sensitivity pattern, clinical profile and outcome.
Topics: Adolescent; Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Chloramphenicol Resistance; Ciprofloxacin; Drug Resistance, Multiple; Female; Humans; India; Infant; Male; Typhoid Fever | 1994 |
Antimicrobial activity of cefepime tested against Bush group I beta-lactamase-producing strains resistant to ceftazidime. A multilaboratory national and international clinical isolate study.
Topics: beta-Lactamases; Cefepime; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Cross Infection; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; International Cooperation; Microbial Sensitivity Tests | 1994 |
Antimicrobial activity of a new antipseudomonal dual-action drug, Ro 25-0534.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fleroxacin; Fluoroquinolones; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure | 1994 |
A statistical evaluation of the bactericidal effects of ceftibuten in combination with aminoglycosides and ciprofloxacin.
Topics: Aminoglycosides; Anti-Bacterial Agents; Ceftibuten; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Klebsiella pneumoniae; Microbial Sensitivity Tests; Statistics as Topic | 1993 |
[In vitro antibacterial activity and clinical significance of domestic fluoroquinolones combinations with other antimicrobial agents].
Topics: Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Positive Cocci; Pseudomonas aeruginosa | 1993 |
Activity of imipenem, third-generation cephalosporins, aztreonam and ciprofloxacin against multi-resistant gram-negative bacilli isolated from Chilean hospitals.
Topics: Anti-Bacterial Agents; Aztreonam; Cephalosporins; Chile; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Drug Synergism; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Indicators and Reagents; Microbial Sensitivity Tests | 1993 |
Dual-action cephalosporins incorporating a 3'-tertiary-amine-linked quinolone.
Topics: beta-Lactamases; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Resistance, Microbial; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Molecular Structure; Nitrogen; Quinolines; Structure-Activity Relationship | 1994 |
Haemophilus influenzae infection of human respiratory mucosa in low concentrations of antibiotics.
Topics: Adenoids; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Child, Preschool; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Microscopy, Electron; Mucociliary Clearance; Mucous Membrane; Organ Culture Techniques; Respiratory Tract Infections | 1993 |
Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.
Topics: Amikacin; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Fusidic Acid; Gentamicins; Imipenem; Methicillin Resistance; Microbial Sensitivity Tests; Mutation; Pseudomonas aeruginosa; Staphylococcus aureus | 1993 |
In vitro susceptibility of Borrelia burgdorferi to 11 antimicrobial agents.
Topics: Anti-Bacterial Agents; Borrelia burgdorferi Group; Cephalosporins; Ciprofloxacin; Humans; Macrolides; Microbial Sensitivity Tests; Ofloxacin | 1993 |
Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coli.
Topics: Amines; Anti-Infective Agents; Bacterial Proteins; Carrier Proteins; Cefotaxime; Ceftriaxone; Cell Nucleus; Cephalosporins; Ciprofloxacin; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Structure-Activity Relationship; Topoisomerase II Inhibitors | 1993 |
Epileptogenic effect of antibiotic drugs.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Ciprofloxacin; Clindamycin; Electroencephalography; Epilepsy; Erythromycin; Hippocampus; Humans; In Vitro Techniques; Penicillins; Rats; Rats, Wistar; Vancomycin | 1993 |
Salmonella: a rare cause of meningitis in an adult.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Humans; Immunocompromised Host; Lupus Erythematosus, Systemic; Meningitis, Bacterial; Middle Aged; Salmonella Infections | 1995 |
An audit of ciprofloxacin use in a district general hospital.
Topics: Anti-Infective Agents; Bacterial Infections; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Utilization Review; Hospitals, General; Humans; Ofloxacin; Postoperative Complications; United Kingdom | 1995 |
[Activities of antipseudomonal agents against clinical isolates of Pseudomonas aeruginosa].
Topics: Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Pseudomonas aeruginosa; Serotyping; Sputum; Suppuration; Urine | 1995 |
In vitro activity of ofloxacin, ciprofloxacin, and cefoperazone alone and in combination against Xanthomonas maltophilia.
Topics: Anti-Infective Agents; Cefoperazone; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Drug Therapy, Combination; Kinetics; Microbial Sensitivity Tests; Ofloxacin; Time Factors; Xanthomonas | 1995 |
In vitro activities of ciprofloxacin, cefotaxime, ceftriaxone, chloramphenicol, and rifampin against fully susceptible and moderately penicillin-resistant Neisseria meningitidis.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Disease Outbreaks; Humans; Meningococcal Infections; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin Resistance; Rifampin | 1995 |
Ciprofloxacin resistant Neisseria gonorrhoea in New Zealand.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; New Zealand | 1996 |
Impact of different classes antimicrobial agents on plasma endotoxin activity.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Blood Pressure; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Disease Models, Animal; Endotoxins; Escherichia coli; Escherichia coli Infections; Gentamicins; Imipenem; Male; Peritoneal Diseases; Peritoneum; Rats; Rats, Wistar; Thienamycins | 1996 |
Relationship between outer membrane protein profiles and resistance to ceftazidime, imipenem, and ciprofloxacin in Pseudomonas aeruginosa isolates from bacteremic patients.
Topics: Anti-Infective Agents; Bacteremia; Bacterial Outer Membrane Proteins; Ceftazidime; Cephalosporins; Ciprofloxacin; Humans; Imipenem; Pseudomonas aeruginosa; Thienamycins | 1996 |
[Kinetics of bactericidal activity of cefepime and cefpirome alone or combined with gentamicin, amikacin or ciprofloxacin against Acinetobacter baumannii, Stenotrophomonas maltophilia and Enterobacter cloacae hyperproductive in cephalosporinase].
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cefpirome; Cephalosporinase; Cephalosporins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enterobacter cloacae; Gentamicins; In Vitro Techniques; Xanthomonas | 1996 |
Single-dose intrapulmonary pharmacokinetics of azithromycin, clarithromycin, ciprofloxacin, and cefuroxime in volunteer subjects.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Drug Administration Schedule; Epithelium; Female; Humans; Male; Pulmonary Alveoli | 1996 |
Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.
Topics: Bacteria; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Enterobacter cloacae; Escherichia coli; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus; Tobramycin | 1996 |
An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Cefotaxime; Ceftazidime; Cefuroxime; Cephalosporins; Ciprofloxacin; Costs and Cost Analysis; Disease Outbreaks; Drug Resistance, Microbial; Drug Resistance, Multiple; Gentamicins; Humans; Klebsiella Infections; Klebsiella pneumoniae; Scotland | 1996 |
AUIC--a general target for the optimization of dosing regimens of antibiotics?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefmenoxime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Models, Biological; Tobramycin | 1996 |
Susceptibility testing of Haemophilus influenzae--an international collaborative study in quality assessment.
Topics: Ampicillin; Ampicillin Resistance; beta-Lactamases; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Greece; Haemophilus influenzae; Microbial Sensitivity Tests; Norway; Poland; Sweden; Switzerland; Tetracycline; Trimethoprim; Turkey; United Kingdom; United States | 1996 |
Mycotic aneurysm due to non-typhi salmonella: report of 16 cases.
Topics: Aged; Ampicillin; Aneurysm, Infected; Anti-Bacterial Agents; Arteriosclerosis; Bacteremia; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Mortality; Penicillins; Retrospective Studies; Salmonella; Salmonella Infections; Seroepidemiologic Studies; Tomography, X-Ray Computed; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacter; Gram-Negative Aerobic Bacteria; Gram-Negative Bacterial Infections; Hospital Bed Capacity; Hospitals, Teaching; Humans; Imipenem; Intensive Care Units; Klebsiella pneumoniae; Lung; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Pseudomonas aeruginosa; Risk Factors; Thienamycins; Wounds and Injuries | 1996 |
Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Ceftazidime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Therapy, Combination; Enterobacter cloacae; Enzyme Inhibitors; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Monobactams; Penicillanic Acid; Penicillins; Piperacillin; Pseudomonas aeruginosa; Serratia marcescens; Tazobactam; Ticarcillin; Time Factors | 1996 |
The synergic effects of quinolones and oral cephem antibiotics on Serratia marcescens.
Topics: Anti-Infective Agents; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Ofloxacin; Serratia marcescens | 1996 |
Changing spectrum of typhoid.
Topics: Adolescent; Adult; Anti-Infective Agents; Bone Marrow Examination; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Humans; Male; Sensitivity and Specificity; Typhoid Fever | 1996 |
In-vitro activity of antimicrobial agent combinations against multiresistant Acinetobacter baumannii.
Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1996 |
[Disseminated liver abscesses in yersiniosis: diagnosis by ultrasound and spiral CT].
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Female; Humans; Liver Abscess; Middle Aged; Tomography, X-Ray Computed; Ultrasonography; Yersinia Infections | 1996 |
In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Bacteremia; Catheterization, Central Venous; Cefamandole; Cephalosporins; Ciprofloxacin; Clindamycin; Daptomycin; Humans; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Neoplasms; Novobiocin; Oxacillin; Penicillins; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Staphylococcus epidermidis; Teicoplanin; Vancomycin; Virginiamycin | 1996 |
Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae.
Topics: Amino Acid Sequence; Anti-Infective Agents; Base Sequence; Cephalosporins; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; DNA Topoisomerases, Type II; Genes, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Molecular Sequence Data; Mutation; Nalidixic Acid; Polymerase Chain Reaction | 1997 |
Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Ciprofloxacin; Drug Hypersensitivity; Endocarditis, Bacterial; Endoscopy, Gastrointestinal; Gentamicins; Humans; Immunocompromised Host; Metronidazole; Neutropenia; Pancreatic Pseudocyst; Penicillins; Risk Factors; Teicoplanin; Vancomycin | 1997 |
Bactericidal eradication from carious lesions of prepared abutments by an antibacterial temporary cement.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Cefaclor; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Crowns; Dental Abutments; Dental Caries; Dental Leakage; Dental Restoration, Temporary; Humans; Metronidazole; Middle Aged; Polycarboxylate Cement; Tooth Preparation, Prosthodontic | 1997 |
In vitro activity of fosfomycin combined with ceftazidime, imipenem, amikacin, and ciprofloxacin against Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Fosfomycin; Imipenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Thienamycins | 1997 |
Hospital-acquired Clostridium difficile diarrhoea.
Topics: Anti-Infective Agents; Cefuroxime; Cephalosporins; Ciprofloxacin; Clostridioides difficile; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Penicillins; Thoracic Diseases | 1997 |
Comparison of antibacterial activities of meropenem and six other antimicrobials against Pseudomonas aeruginosa isolates from North American studies and clinical trials.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Drug Resistance, Microbial; Gentamicins; Humans; Imipenem; Isoelectric Focusing; Meropenem; Microbial Sensitivity Tests; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin | 1997 |
[Discitis in childhood: integrated neuroradiological imaging in diagnosis and follow-up study of one case].
Topics: Anti-Infective Agents; Cefotaxime; Cephalosporins; Child; Ciprofloxacin; Discitis; Female; Humans; Lumbosacral Region; Magnetic Resonance Imaging; Teicoplanin | 1997 |
Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture.
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Fallopian Tubes; Female; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Organ Culture Techniques | 1997 |
Is it possible to prevent bacterial adhesion onto ureteric stents?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Adhesion; Bacteriological Techniques; Ceftriaxone; Cephalosporins; Ciprofloxacin; Escherichia coli; Humans; Materials Testing; Stents; Tobramycin; Ureter; Urinary Tract Infections | 1997 |
Clostridium difficile infection in obstetric and gynecologic patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Bacterial Toxins; Cefoxitin; Cephalexin; Cephalosporins; Cephamycins; Ciprofloxacin; Clindamycin; Clostridioides difficile; Colonoscopy; Diarrhea; Enterocolitis, Pseudomembranous; Female; Fever; Gentamicins; Humans; Imipenem; Incidence; Middle Aged; Nausea; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination; Vomiting | 1997 |
Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteremia; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospital Mortality; Humans; Incidence; Male; Middle Aged; Pneumonia, Bacterial; Prospective Studies; Respiration, Artificial | 1997 |
Comparative in vitro evaluation of piperacillin/tazobactam in a tertiary care hospital.
Topics: Amoxicillin; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Enzyme Inhibitors; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Penicillins; Piperacillin; Tazobactam | 1997 |
Antimicrobial resistance in Neisseria gonorrhoeae in Finland, 1976 to 1995. The Finnish Study Group For Antimicrobial Resistance.
Topics: Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Time Factors | 1997 |
The relationship between the use of flucloxacillin, vancomycin, aminoglycosides and ciprofloxacin and the susceptibility patterns of coagulase-negative staphylococci recovered from blood cultures.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Coagulase; Drug Resistance, Microbial; Floxacillin; Humans; Microbial Sensitivity Tests; Penicillins; Sepsis; Streptococcal Infections; Streptococcus; Vancomycin | 1997 |
Spinal abscess of Haemophilus paraphrophilus. A case report.
Topics: Abscess; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Haemophilus; Haemophilus Infections; Humans; Lumbar Vertebrae; Magnetic Resonance Imaging; Middle Aged; Spinal Diseases | 1997 |
Quinolone-resistant Salmonella paratyphi B meningitis in a newborn: a case report.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Imipenem; Infant, Newborn; Infant, Premature, Diseases; Meningitis, Bacterial; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi B; Thienamycins; Tomography, X-Ray Computed | 1997 |
[Treatment of lower respiratory tract infections in the elderly].
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Bronchitis; Cefaclor; Cephalosporins; Chronic Disease; Ciprofloxacin; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Penicillins | 1997 |
Pneumococcal resistance in the UK.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Multiple; Fluoroquinolones; Humans; Macrolides; Microbial Sensitivity Tests; Northern Ireland; Ofloxacin; Oxacillin; Penicillin Resistance; Penicillins; Piperazines; Pneumococcal Infections; Quinolones; Retrospective Studies; Streptococcus pneumoniae; Tetracycline | 1997 |
Emerging drug resistance and vaccination for typhoid fever.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Salmonella typhi; Typhoid Fever | 1998 |
Gram-negative bacilli isolated from patients in intensive care unit: prevalence and antibiotic susceptibility.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Blood; Carbapenems; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Gram-Negative Bacteria; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Respiratory Tract Infections; Saudi Arabia; Urinary Tract Infections; Wounds and Injuries | 1997 |
Antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens isolated in the UK during the 1995-1996 cold season.
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Bacteria; Bacterial Infections; beta-Lactam Resistance; beta-Lactamases; Cefaclor; Cephalosporins; Ciprofloxacin; Clarithromycin; Common Cold; Community-Acquired Infections; Dose-Response Relationship, Drug; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Multicenter Studies as Topic; Penicillins; Respiratory System; Respiratory Tract Infections; Streptococcus pneumoniae; United Kingdom | 1998 |
Surveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95.
Topics: Adult; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Netherlands; Penicillinase; Prevalence; Retrospective Studies; Tetracycline Resistance | 1997 |
Facial nerve paralysis in acute otitis media: cause and management revisited.
Topics: Acute Disease; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Audiometry; Bone Conduction; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Facial Paralysis; Female; Follow-Up Studies; Glucocorticoids; Hearing Loss; Hearing Loss, Conductive; Humans; Male; Middle Aged; Otitis Media; Penicillins; Prednisone; Trimethoprim, Sulfamethoxazole Drug Combination; Tympanic Membrane | 1998 |
Cefaclor: a contemporary look at susceptibility of key pathogens from around the globe.
Topics: Anti-Infective Agents; Cefaclor; Cephalosporins; Ciprofloxacin; Escherichia coli; Haemophilus influenzae; Methicillin Resistance; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Staphylococcus aureus | 1998 |
Transferable trimethoprim resistance in Shigella strains.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Ceftazidime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Conjugation, Genetic; Drug Therapy, Combination; Microbial Sensitivity Tests; Nalidixic Acid; Penicillins; Plasmids; Shigella; Trimethoprim; Trimethoprim Resistance | 1998 |
Perioperative antibiotic prophylaxis in abdominal surgery for hernia repair: retrospective study of 1,524 consecutive patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Antibiotic Prophylaxis; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Herniorrhaphy; Humans; Male; Middle Aged; Pefloxacin; Retrospective Studies; Surgical Wound Infection; Treatment Outcome | 1998 |
Haemophilus paraphrophilus; a rare cause of intracranial abscess.
Topics: Adult; Brain; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Haemophilus; Haemophilus Infections; Humans; Male; Stereotaxic Techniques; Tomography, X-Ray Computed | 1998 |
Influence of ciprofloxacin and other antimicrobial drugs on different Escherichia coli strains in continuous-flow cultures under aerobic and anaerobic conditions.
Topics: Aerobiosis; Anaerobiosis; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Culture Media; Escherichia coli; Feces; Gentamicins; Mezlocillin; Penicillins | 1998 |
Increasing resistance of planktonic and biofilm cultures of Burkholderia cepacia to ciprofloxacin and ceftazidime during exponential growth.
Topics: Animals; Anti-Infective Agents; Biofilms; Burkholderia cepacia; Ceftazidime; Cell Cycle; Cell Division; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Plankton | 1998 |
Cefepime--assessment of its need at a tertiary care center.
Topics: Adult; Aged; Anti-Infective Agents; Cefepime; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Cohort Studies; Drug Utilization Review; Female; Hospitals, University; Humans; Imipenem; Male; Middle Aged; Prospective Studies; Switzerland; Thienamycins | 1998 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
[Trends and changes in antimicrobial resistance of clinical isolates from 11 hospitals in Beijing area].
Topics: Anti-Infective Agents; Ceftazidime; Cephalosporins; China; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Humans; Klebsiella; Quinolones; Streptococcus pneumoniae | 1997 |
[Ampicillin-sulbactam activity against respiratory isolates of Haemophilus influenzae].
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Penicillins; Respiratory Tract Infections; Sulbactam | 1998 |
[Standardization of the Neisseria meningitidis antibiogram. Detection of strains relatively resistant to penicillin].
Topics: Amoxicillin; Ampicillin; Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Cefotaxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Microbial Sensitivity Tests; Neisseria meningitidis; Penicillin G; Penicillin Resistance; Penicillins; Rifampin; Spiramycin | 1998 |
In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Clindamycin; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Ofloxacin; Quinolones; Staphylococcal Infections; Staphylococcus | 1995 |
Sensitivity pattern and beta-lactamase production in clinical isolates of Aeromonas strains.
Topics: Aeromonas; Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefotaxime; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Microbial; Gram-Negative Bacterial Infections; Humans; Imipenem; Microbial Sensitivity Tests; Pakistan; Thienamycins; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
Antimicrobial susceptibility testing for Klebsiella pneumoniae isolates resistant to extended-spectrum beta-lactam antibiotics.
Topics: Anti-Infective Agents; Aztreonam; beta-Lactam Resistance; beta-Lactamases; Cephalosporins; Ciprofloxacin; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Monobactams; Ofloxacin; Thienamycins | 1998 |
Antibiotic usage and methicillin-resistant Staphylococcus aureus: an analysis of causality.
Topics: Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Drug Utilization; Hospitalization; Humans; Matched-Pair Analysis; Methicillin Resistance; Pilot Projects; Staphylococcal Infections; Staphylococcus aureus | 1998 |
Canadian Pseudomonas aeruginosa susceptibility study from 48 medical centers: focus on ciprofloxacin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Canada; Carbenicillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Geography; Hospitals; Humans; Imipenem; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Ticarcillin; Urinary Tract Infections | 1998 |
Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Fusobacterium; Imipenem; Lactams; Metronidazole; Microbial Sensitivity Tests; Peptostreptococcus; Veillonella | 1998 |
Failure of mass antibiotic prophylaxis to control a prolonged outbreak of meningococcal disease in an Israeli village.
Topics: Adolescent; Adult; Age Distribution; Anti-Infective Agents; Antibiotic Prophylaxis; Carrier State; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Disease Outbreaks; Humans; Incidence; Infant; Infant, Newborn; Israel; Meningococcal Infections; Neisseria meningitidis; Pharynx; Rural Health | 1998 |
Antibacterial activity of meropenem against Pseudomonas aeruginosa, including antibiotic-induced morphological changes and endotoxin-liberating effects.
Topics: Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Endotoxins; Humans; Imipenem; Lipopolysaccharides; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1998 |
Brain abscess caused by Salmonella enteritidis in an immunocompetent adult patient: successful treatment with cefotaxime and ciprofloxacin.
Topics: Adult; Anti-Infective Agents; Brain Abscess; Cefotaxime; Cephalosporins; Ciprofloxacin; Enteritis; Humans; Immunocompetence; Male; Salmonella Infections | 1998 |
Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillin Resistance; Respiratory Tract Infections; Streptococcus pneumoniae | 1999 |
Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy.
Topics: Aged; Anti-Infective Agents; Area Under Curve; Ceftazidime; Cephalosporins; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Microbial Sensitivity Tests; Penicillins; Piperacillin; Predictive Value of Tests; Respiratory Tract Infections; Thienamycins; Treatment Outcome | 1999 |
Development of resistance and cross-resistance in Pseudomonas aeruginosa exposed to subinhibitory antibiotic concentrations.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azlocillin; Ceftazidime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 1999 |
Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Topics: Amoxicillin; Anti-Infective Agents; Ceftriaxone; Cefuroxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Fluoroquinolones; Gatifloxacin; Levofloxacin; Microbial Sensitivity Tests; Naphthyridines; Ofloxacin; Penicillin Resistance; Streptococcus pneumoniae | 1999 |
Investigation of the synergic effects of aminoglycoside-fluoroquinolone and third-generation cephalosporin combinations against clinical isolates of Pseudomonas spp.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefoperazone; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Netilmicin; Pefloxacin; Pseudomonas | 1999 |
Pharmacokinetics of cefpirome during the posttraumatic systemic inflammatory response syndrome.
Topics: Adult; Anti-Infective Agents; Case-Control Studies; Cefpirome; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Humans; Infusions, Intravenous; Least-Squares Analysis; Male; Metabolic Clearance Rate; Middle Aged; Prospective Studies; Statistics, Nonparametric; Systemic Inflammatory Response Syndrome; Wounds and Injuries | 1999 |
Nosocomial meningitis in children after ventriculoperitoneal shunt insertion.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Postoperative Complications; Retrospective Studies; Risk Factors; Vancomycin; Ventriculoperitoneal Shunt | 1999 |
Adsorption and release of antibiotics from morselized cancellous bone. In vitro studies of 8 antibiotics.
Topics: Adsorption; Anti-Bacterial Agents; Biological Assay; Bone Transplantation; Cephalosporins; Ciprofloxacin; Clindamycin; Colony Count, Microbial; Drug Carriers; Drug Evaluation, Preclinical; Drug Stability; Humans; Netilmicin; Penicillin G; Rifampin; Temperature; Time Factors; Transplantation, Homologous; Vancomycin | 1999 |
Construction of mutant strains of Neisseria gonorrhoeae lacking new antibiotic resistance markers using a two gene cassette with positive and negative selection.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Cloning, Molecular; Drug Resistance, Microbial; Escherichia coli Proteins; Genetic Markers; Humans; Male; Models, Genetic; Mutagenesis, Insertional; Neisseria gonorrhoeae; Plasmids; Polymerase Chain Reaction; Ribosomal Protein S9; Ribosomal Proteins; Transformation, Genetic | 1999 |
Endotoxin release due to ciprofloxacin measured by three different methods.
Topics: Anti-Infective Agents; Bacterial Toxins; Ceftazidime; Cephalosporins; Ciprofloxacin; Endotoxins; Enzyme-Linked Immunosorbent Assay; Escherichia coli; Humans; Imipenem; Limulus Test; Lipopolysaccharides; Monocytes; Sensitivity and Specificity; Thienamycins; Tumor Necrosis Factor-alpha | 1999 |
Surveillance of antibiotic resistance in ICUs in southeastern Sweden. ICU Study Group of the South East of Sweden.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; Anti-Infective Agents; APACHE; Bacteria; Carbapenems; Cefotaxime; Cephalosporins; Ciprofloxacin; Critical Care; Drug Resistance, Microbial; Drug Utilization; Enterococcus faecalis; Enterococcus faecium; Escherichia coli; Fusidic Acid; Gentamicins; Humans; Netilmicin; Oxacillin; Penicillin Resistance; Penicillins; Population Surveillance; Prevalence; Staphylococcus; Sweden | 1999 |
Nosocomial pneumonia with isolation of anaerobic bacteria in ICU patients: therapeutic considerations and outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacteria, Anaerobic; Cefotaxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Bacterial; Prevotella; Retrospective Studies; Treatment Outcome | 1999 |
National guideline for the management of prostatitis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Adrenergic alpha-Antagonists; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Urinary; Anti-Inflammatory Agents, Non-Steroidal; Cephalosporins; Chronic Disease; Ciprofloxacin; Humans; Male; Ofloxacin; Prostatitis; Urinary Tract Infections | 1999 |
Ciprofloxacin inhibition of experimental fracture healing.
Topics: Animals; Anti-Infective Agents; Biomechanical Phenomena; Cefazolin; Cephalosporins; Ciprofloxacin; Depression, Chemical; Drug Evaluation, Preclinical; Femoral Fractures; Femur; Fracture Healing; Male; Radiography; Rats; Rats, Wistar; Time Factors | 2000 |
[Penetration of ciprofloxacin and cefoperazone into human pancreas].
Topics: Adult; Ampulla of Vater; Anti-Infective Agents; Cefoperazone; Cephalosporins; Ciprofloxacin; Common Bile Duct Neoplasms; Humans; Middle Aged; Pancreas; Pancreatic Juice; Pancreatitis | 1997 |
In vitro evaluation of antibiotic prophylaxis in the prevention of biliary stent blockage.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Adhesion; Biofilms; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterococcus; Escherichia coli; Humans; In Vitro Techniques; Penicillins; Polyethylene; Stents | 2000 |
[In vitro activities of levofloxacin and other antibiotics against fresh clinical isolates].
Topics: Ampicillin; Anti-Infective Agents; Bacteria; Bacterial Infections; Cefaclor; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Humans; Levofloxacin; Methicillin; Ofloxacin; Penicillin G; Penicillin Resistance; Penicillins | 1999 |
Comparative therapeutic efficacy of clinafloxacin in a pneumococcal meningitis mouse model.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Fluoroquinolones; Meningitis, Pneumococcal; Mice; Microbial Sensitivity Tests; Models, Biological; Streptococcus pneumoniae | 2000 |
Is there a role for antibiotic prophylaxis in transperineal interstitial permanent prostate brachytherapy?
Topics: Anti-Infective Agents; Antibiotic Prophylaxis; Brachytherapy; Cefazolin; Cephalosporins; Ciprofloxacin; Cystoscopy; Drug Administration Routes; Humans; Male; Perineum; Prostatic Neoplasms; Radiotherapy Planning, Computer-Assisted; Treatment Outcome; Urinary Tract Infections | 2000 |
Pasteurella multocida: a case report of bacteremic pneumonia and 10-year laboratory review.
Topics: Aged; Animals; Ceftriaxone; Cephalosporins; Ciprofloxacin; Dogs; Humans; Male; Pasteurella Infections; Pasteurella multocida; Pneumonia, Bacterial; Zoonoses | 2000 |
[Impossible treatment of gonorrhea].
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Denmark; Drug Costs; Gonorrhea; Humans | 2000 |
Antibiotics for Salmonella meningitis in children.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Meningitis, Bacterial; Salmonella Infections | 2000 |
[Some problems of the current therapy of infective endocarditis].
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Cross Infection; Drug Therapy, Combination; Echocardiography; Endocarditis, Bacterial; Follow-Up Studies; Gentamicins; Humans; Male; Oxacillin; Plasmapheresis; Recurrence; Time Factors | 2000 |
Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cell Count; Cephalosporins; Ciprofloxacin; Diagnostic Imaging; DNA, Bacterial; Escherichia coli; Escherichia coli Infections; Luminescent Measurements; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Muscular Diseases; Neutropenia; Tetracycline | 2001 |
Successful use of recombinant tissue plasminogen activator in a patient with relapsing peritonitis.
Topics: Adult; Cefepime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Gentamicins; Humans; Injections, Intraperitoneal; Male; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Recombinant Proteins; Recurrence; Remission Induction; Tissue Plasminogen Activator; Vancomycin | 2001 |
Relapse of multiresistant Salmonella typhi after combined therapy with ciprofloxacin and ceftriaxone.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Recurrence; Salmonella typhi; Typhoid Fever | 2000 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Comparative activities of isepamicin, amikacin, cefepime, and ciprofloxacin alone or in combination with other antibiotics against Stenotrophomonas maltophilia.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Cefepime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; Gentamicins; Gram-Negative Bacterial Infections; Microbial Sensitivity Tests; Stenotrophomonas maltophilia; Time Factors | 2001 |
Non-serogroup O:1 Vibrio cholerae bacteremia and cerebritis.
Topics: Adult; Anti-Infective Agents; Bacteremia; Cefotaxime; Cephalosporins; Cholera; Ciprofloxacin; Humans; Male; Meningitis, Bacterial; Vibrio cholerae | 2001 |
Antimicrobial susceptibility of Listeria monocytogenes isolated from meningoencephalitis in sheep.
Topics: Amoxicillin; Animal Feed; Animals; Anti-Bacterial Agents; Brain; Cephalosporins; Cephalothin; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Resistance, Microbial; Erythromycin; Gentamicins; Kanamycin; Listeria monocytogenes; Listeriosis; Meningoencephalitis; Microbial Sensitivity Tests; Penicillin G; Penicillins; Rifampin; Sheep; Sheep Diseases; Sulfisoxazole; Tetracycline; Trimethoprim; Vancomycin | 2001 |
Primary meningococcal arthritis in the elderly.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Arthritis, Infectious; Cefuroxime; Cephalosporins; Ciprofloxacin; Humans; Injections, Intravenous; Knee Joint; Male; Meningococcal Infections; Neisseria meningitidis; Synovial Fluid; Treatment Outcome | 2001 |
Post-antibiotic and synergic effects of fluoroquinolones and ceftazidime in combination against Pseudomonas strains.
Topics: Anti-Infective Agents; Ceftazidime; Cephalosporins; Ciprofloxacin; Comamonas testosteroni; Drug Synergism; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas Infections | 2001 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from three Caribbean countries: Trinidad, Guyana, and St. Vincent.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Gonorrhea; Guyana; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Prevalence; Saint Vincent and the Grenadines; Spectinomycin; Tetracycline Resistance; Trinidad and Tobago | 2001 |
Ciprofloxacin susceptible Salmonella typhi with treatment failure.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Microbial; Humans; India; Microbial Sensitivity Tests; Salmonella typhi; Treatment Failure; Typhoid Fever | 2001 |
A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Cefuroxime; Cephalosporins; Chronic Disease; Ciprofloxacin; Disease Models, Animal; Male; Osteomyelitis; Rats; Rats, Wistar; Staphylococcal Infections; Staphylococcus aureus; Tibia; Tobramycin; Vancomycin | 2001 |
Effects of antibiotics on morphologic characteristics and migration of canine corneal epithelial cells in tissue culture.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefazolin; Cell Movement; Cephalosporins; Chloramphenicol; Ciprofloxacin; Cornea; Culture Techniques; Dogs; Epithelial Cells; Gentamicins; Statistics, Nonparametric; Tobramycin | 2001 |
Attempts to stem Anthrax fears stumble.
Topics: Adrenal Cortex Hormones; Anthrax; Bacillus anthracis; Bioterrorism; Centers for Disease Control and Prevention, U.S.; Cephalosporins; Ciprofloxacin; Contraindications; Doxycycline; Drug Therapy, Combination; Humans; Occupational Exposure; Penicillins; Postal Service; Respiratory Tract Infections; Skin Diseases, Bacterial; Spores, Bacterial; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 2001 |
Transfusion-mediated Yersinia enterocolitica septicemia in an adult patient with beta-thalassemia.
Topics: Adult; Anti-Infective Agents; beta-Thalassemia; Ceftriaxone; Cephalosporins; Ciprofloxacin; Female; Humans; Transfusion Reaction; Treatment Outcome; Yersinia enterocolitica; Yersinia Infections | 2001 |
Antibiotic resistant N. gonorrhoeae in Trinidad and Tobago.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Gonorrhea; Health Behavior; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillinase; Penicillins; Prevalence; Spectinomycin; Tetracycline; Tetracycline Resistance; Trinidad and Tobago | 2001 |
Effects of parenterally administered ciprofloxacin in a murine model of pulmonary Pseudomonas aeruginosa infection mimicking ventilator-associated pneumonia.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Cefozopran; Cephalosporins; Cilastatin; Ciprofloxacin; Disease Models, Animal; Imipenem; Infusions, Parenteral; Male; Mice; Pneumonia, Bacterial; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Respiration, Artificial; Thienamycins | 2001 |
Ceftriaxone therapy in ciprofloxacin treatment failure typhoid fever in children.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Humans; Typhoid Fever | 2001 |
In vitro synergy testing of levofloxacin, ofloxacin, and ciprofloxacin in combination with aztreonam, ceftazidime, or piperacillin against Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Aztreonam; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Synergism; Humans; Lactams; Levofloxacin; Microbial Sensitivity Tests; Monobactams; Ofloxacin; Penicillins; Piperacillin; Pseudomonas aeruginosa | 2002 |
Diagnostic dilemma in coinfection.
Topics: Adolescent; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Entamoebiasis; Female; Humans; Methicillin Resistance; Peritonsillar Abscess; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Typhoid Fever | 2001 |
Minimal inhibitory concentrations and time-kill determination of moxifloxacin against aerobic and anaerobic isolates.
Topics: Aerobiosis; Anaerobiosis; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Bacteria; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Clostridium; Drug Resistance, Multiple, Bacterial; Erythromycin; Fluoroquinolones; Imipenem; Microbial Sensitivity Tests; Moxifloxacin; Mycoplasma; Quinolines; Streptococcus; Teicoplanin; Thienamycins; Vancomycin | 2002 |
[Activity of new fluoroquinolones against clinical isolates of Acinetobacter baumannii].
Topics: Acinetobacter; Acinetobacter Infections; Ampicillin; Anti-Infective Agents; Aza Compounds; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Fluoroquinolones; Gatifloxacin; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Moxifloxacin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Opportunistic Infections; Quinolines; Sulbactam; Thienamycins | 2001 |
Assessment and treatment of low-risk febrile neutropenic (LRFN) pediatric patients with cancer.
Topics: Anti-Infective Agents; Ceftriaxone; Cephalosporins; Child; Ciprofloxacin; Fever; Humans; Neoplasms; Neutropenia; Risk Factors | 2002 |
Ciprofloxacin-resistant typhoid with incomplete response to cefotaxime.
Topics: Adolescent; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Salmonella typhi; Treatment Outcome; Typhoid Fever | 2002 |
Changing pattern of bacterial susceptibility to antibiotics in hematopoietic stem cell transplant recipients.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Bacterial Infections; Belgium; Carbapenems; Cephalosporins; Ciprofloxacin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Enterococcus; Follow-Up Studies; Gram-Negative Bacteria; Hematopoietic Stem Cell Transplantation; Humans; Microbial Sensitivity Tests; Retrospective Studies; Staphylococcus; Streptococcus; Transplantation, Autologous; Transplantation, Homologous | 2002 |
[Borrelia burgdorferi Group: in-vitro antibiotic sensitivity].
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Borrelia burgdorferi Group; Cephalosporins; Ciprofloxacin; Erythromycin; In Vitro Techniques; Microbial Sensitivity Tests; Penicillin G; Penicillins; Tetracycline | 2002 |
Intracranial infection due to non-typhoidal Salmonella: report of four cases.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Central Nervous System Bacterial Infections; Cephalosporins; Ciprofloxacin; Diabetes Mellitus, Type 2; Gentamicins; Humans; Male; Middle Aged; Salmonella enteritidis; Salmonella Infections; Salmonella typhimurium | 2002 |
Diagnosis of Actinobacillus actinomycetemcomitans infective endocarditis after steadily negative blood cultures.
Topics: Actinobacillus Infections; Adult; Aggregatibacter actinomycetemcomitans; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans | 2002 |
In-vitro activity of ciprofloxacin combined with flomoxef against Bacteroides fragilis, compared with that of ciprofloxacin combined with clindamycin.
Topics: Bacteroides fragilis; Cephalosporins; Ciprofloxacin; Clindamycin; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests | 2002 |
Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Critical Care; Cystic Fibrosis; Data Collection; Drug Resistance, Bacterial; Europe; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Neutropenia; Penicillanic Acid; Piperacillin; Population Surveillance; Proteus Infections; Proteus mirabilis; Tazobactam; Thienamycins | 2002 |
The efficacy of prophylactic outpatient antibiotics for the prevention of neutropenic fever associated with high-dose etoposide (VP-16) for stem cell mobilization.
Topics: Ambulatory Care; Antibiotic Prophylaxis; Cefepime; Cephalosporins; Ciprofloxacin; Clarithromycin; Data Collection; Drug Therapy, Combination; Etoposide; Female; Fever; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Neutropenia; Opportunistic Infections; Vancomycin | 2002 |
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
Topics: Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sensitivity and Specificity; Tazobactam | 2002 |
[Antibacterial activity of gatifloxacin against various fresh clinical isolates in 2002].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Cefdinir; Cephalosporins; Ciprofloxacin; Dosage Forms; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Levofloxacin; Macrolides; Ofloxacin; Otorhinolaryngologic Diseases; Respiratory Tract Infections; Staphylococcus aureus; Streptococcus pneumoniae; Time Factors; Urinary Tract Infections | 2002 |
[Bacterial resistance to antibiotics in gram-negative rods isolated from intensive care units. Comparative analysis between two periods (1998 and 2001)].
Topics: Acinetobacter; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Argentina; Cephalosporins; Child; Ciprofloxacin; Drug Resistance, Microbial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Infant, Newborn; Intensive Care Units; Klebsiella pneumoniae; Male; Middle Aged; Prospective Studies | 2003 |
[Combined infection of abdominal typhoid and hepatitis A and E].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Diagnosis, Differential; Endemic Diseases; Hepatitis A Virus, Human; Hepatitis E virus; Hepatitis, Viral, Human; Humans; Male; Ofloxacin; Salicylates; Tajikistan; Typhoid Fever | 2003 |
[Urinary microflora in children from different pediatric departments].
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Cephalosporins; Child; Ciprofloxacin; Escherichia coli; Gentamicins; Humans; Inpatients; Microbial Sensitivity Tests; Nitrofurantoin; Outpatients; Staphylococcus aureus; Urine | 2003 |
[Meningitis caused by multiresistant E. coli after an echo-directed transrectal biopsy].
Topics: Aged; Amoxicillin; Biopsy; Brain Damage, Chronic; Cefepime; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Confusion; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Male; Meningitis, Bacterial; Premedication; Prostate; Rectum; Ultrasonography; Vancomycin | 2003 |
Antimicrobial spectrum of activity for meropenem and nine broad spectrum antimicrobials: report from the MYSTIC Program (2002) in North America.
Topics: Anti-Bacterial Agents; Aztreonam; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple; Female; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Meropenem; Microbial Sensitivity Tests; North America; Sensitivity and Specificity; Thienamycins; Tobramycin | 2003 |
[Cefepime (maxipime) in the treatment of severe urinary tract infection].
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Sensitivity and Specificity; Treatment Outcome; Urinary Tract Infections | 2003 |
Virulence of metallo-beta-lactamase-producing Pseudomonas aeruginosa in vitro and in vivo.
Topics: Animals; Bacteremia; beta-Lactamases; Ceftazidime; Cephalosporins; Cilastatin; Ciprofloxacin; Drug Therapy, Combination; Imipenem; Leukopenia; Male; Mice; Mice, Inbred BALB C; Protease Inhibitors; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cells; Thienamycins | 2004 |
In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Taiwan | 2004 |
Beta-lactam susceptibilities and prevalence of ESBL-producing isolates among more than 5000 European Enterobacteriaceae isolates.
Topics: Aztreonam; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Enterobacteriaceae Infections; Europe; Humans; Klebsiella; Klebsiella Infections; Microbial Sensitivity Tests | 2004 |
Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Bacteremia; Case-Control Studies; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacter; Enterobacteriaceae Infections; Female; Hospitals, University; Humans; Korea; Male; Middle Aged; Risk Factors | 2005 |
Risk factors for acquisition of methicillin-resistant Staphylococcus aureus (MRSA) by patients with cystic fibrosis.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Child; Child, Preschool; Chronic Disease; Ciprofloxacin; Cystic Fibrosis; Female; Humans; Length of Stay; Male; Methicillin; Methicillin Resistance; Retrospective Studies; Risk Factors; Staphylococcal Infections; Staphylococcus aureus | 2005 |
Bacteremia among Kenyan Children.
Topics: Bacteremia; Cephalosporins; Ciprofloxacin; Fever of Unknown Origin; Ghana; Humans; Microbial Sensitivity Tests; Salmonella typhi | 2005 |
Fourth-generation cephalosporins: in vitro activity against nosocomial gram-negative bacilli compared with beta-lactam antibiotics and ciprofloxacin.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Hospitals, University; Humans; Klebsiella; Microbial Sensitivity Tests; Pseudomonas aeruginosa | 2005 |
Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime.
Topics: Anti-Infective Agents; Cefepime; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Selection, Genetic | 2005 |
Study of clinical profile and antibiotic response in typhoid fever.
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Chloramphenicol; Ciprofloxacin; Drug Resistance, Bacterial; Female; Hospitals, County; Hospitals, Teaching; Humans; Male; Microbial Sensitivity Tests; Retrospective Studies; Salmonella typhi; Trimethoprim, Sulfamethoxazole Drug Combination; Typhoid Fever | 2005 |
Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporin Resistance; Cephalosporins; Ciprofloxacin; Humans; Microbial Sensitivity Tests; Prevalence; Salmonella enterica; Salmonella Infections; Serotyping; Taiwan | 2005 |
Pharmacodynamics of antimicrobials for the empirical treatment of nosocomial pneumonia: a report from the OPTAMA Program.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Cross Infection; Dose-Response Relationship, Drug; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Monte Carlo Method; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Thienamycins | 2005 |
[The combination effects of antibacterial agents against clinical isolated multiple-drug resistant Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Aztreonam; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Humans; Meropenem; Microbial Sensitivity Tests; Oxazines; Penicillanic Acid; Piperacillin; Pseudomonas aeruginosa; Sulbactam; Tazobactam; Thienamycins | 2006 |
[The rate of isolation of Klebsiella pneumoniae producing extended-spectrum beta-lactamases and resistance to antibiotics].
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Bronchi; Carbapenems; Cephalosporins; Ciprofloxacin; Gentamicins; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Piperacillin | 2006 |
Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
Topics: Adolescent; Adult; Ampicillin; Anti-Infective Agents, Urinary; Cefdinir; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Fluoroquinolones; Humans; In Vitro Techniques; Male; Microbial Sensitivity Tests; Middle Aged; Nitrofurantoin; North America; Outpatients; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Treatment of bone and joint infections caused by Gram-negative bacilli with a cefepime-fluoroquinolone combination.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases, Infectious; Cefepime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Female; Gram-Negative Bacterial Infections; Humans; Joint Diseases; Male; Middle Aged; Ofloxacin; Retrospective Studies | 2006 |
[Otitis externa: which antibiotics are first choice?].
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Clindamycin; Drug Therapy, Combination; Humans; Methicillin; Ofloxacin; Ointments; Otitis Externa; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
Urinary bactericidal activity of oral antibiotics against common urinary tract pathogens in an ex vivo model.
Topics: Acetamides; Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; beta-Lactamases; Biomarkers; Cefadroxil; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Middle Aged; Norfloxacin; Oxazolidinones; Time Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2006 |
Community-acquired versus nosocomial Klebsiella pneumoniae bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; APACHE; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2006 |
Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitals.
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Computer Simulation; Drug Administration Schedule; Drug Resistance, Bacterial; Humans; Hungary; Imipenem; Infusions, Intravenous; Meropenem; Microbial Sensitivity Tests; Models, Biological; Monte Carlo Method; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 2006 |
Extended surveillance of gonorrhoea in Scotland 2003.
Topics: Adolescent; Adult; Age Factors; Ambulatory Care Facilities; Anti-Bacterial Agents; Anti-Infective Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Hospitals; Humans; Male; Middle Aged; Neisseria gonorrhoeae; Population Surveillance; Primary Health Care; Scotland; Sexual Behavior; Surveys and Questionnaires | 2006 |
Antibiotic-resistance patterns and frequency of extended-spectrum beta-lactamase-producing isolates of Klebsiella pneumoniae in Tehran.
Topics: Anti-Infective Agents; beta-Lactamases; Cefepime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Drug Resistance, Bacterial; Female; Gentamicins; Humans; Imipenem; Iran; Klebsiella pneumoniae; Male; Meropenem; Thienamycins | 2006 |
Carbapenem-resistant Acinetobacter baumannii: an emerging threat for patients with post-neurosurgical meningitis.
Topics: Acinetobacter baumannii; Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Carbapenems; Cefepime; Cefoperazone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Male; Meningitis, Bacterial; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurosurgical Procedures; Postoperative Complications; Thienamycins; Turkey | 2007 |
Safety and effectiveness of a preoperative allergy clinic in decreasing vancomycin use in patients with a history of penicillin allergy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotic Prophylaxis; beta-Lactams; Cefazolin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Clindamycin; Critical Pathways; Drug Hypersensitivity; Female; Humans; Male; Middle Aged; Penicillins; Preoperative Care; Skin Tests; Treatment Outcome; Vancomycin | 2006 |
[High relationship between ciprofloxacin use and prevalence of ESBL Klebsiella pneumoniae].
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Ciprofloxacin; Cross-Sectional Studies; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Risk Factors | 2006 |
Molecular epidemiology and characterization of resistance mechanisms to various antimicrobial agents in Acinetobacter baumannii isolated in Mérida, Venezuela.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Adult; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; DNA Primers; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Genes, Bacterial; Gentamicins; Humans; Imipenem; Infant, Newborn; Tetracyclines; Venezuela | 2007 |
Community-acquired versus nosocomial Klebsiella pneumonia bacteremia: clinical features, treatment outcomes, and clinical implication of antimicrobial resistance.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Bacterial; Humans; Klebsiella Infections; Klebsiella pneumoniae; Treatment Outcome | 2007 |
Acute bacterial prostatitis in Korea: clinical outcome, including symptoms, management, microbiology and course of disease.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Bacteria; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Humans; Korea; Male; Middle Aged; Prostatitis; Retrospective Studies | 2008 |
Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.
Topics: Ampicillin; Anti-Bacterial Agents; Azithromycin; Cefepime; Cefotaxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Egypt; Hawaii; Humans; Leptospira; Leptospirosis; Levofloxacin; Microbial Sensitivity Tests; Nicaragua; Ofloxacin; Tetracycline; Thailand | 2008 |
Modification in prescribing practices for third-generation cephalosporins and ciprofloxacin is associated with a reduction in meticillin-resistant Staphylococcus aureus bacteraemia rate.
Topics: Anti-Bacterial Agents; Bacteremia; Cephalosporins; Ciprofloxacin; Drug Prescriptions; Hospitals; Humans; Methicillin Resistance; Organizational Policy; Prevalence; Staphylococcal Infections; Staphylococcus aureus | 2008 |
Azithromycin in Pseudomonas aeruginosa biofilms: bactericidal activity and selection of nfxB mutants.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Biofilms; Cefepime; Cephalosporins; Ciprofloxacin; Cystic Fibrosis; DNA-Binding Proteins; Humans; Membrane Proteins; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; MutS DNA Mismatch-Binding Protein; Pseudomonas aeruginosa; Transcription Factors | 2009 |
[Leech-borne infection on a TRAM flap: a case report].
Topics: Aeromonas hydrophila; Cephalosporins; Ciprofloxacin; Female; Gram-Negative Bacterial Infections; Humans; Leeching; Mammaplasty; Middle Aged; Rectus Abdominis; Surgical Flaps | 2010 |
Microbiological analysis of epidermal growth factor receptor inhibitor therapy-associated paronychia.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cephalosporins; Cetuximab; Ciprofloxacin; ErbB Receptors; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Ofloxacin; Paronychia; Retrospective Studies; Skin | 2010 |
Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefepime; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gentamicins; Humans; Imipenem; Korea; Microbial Sensitivity Tests | 2009 |
Tigecycline resistance in Serratia marcescens associated with up-regulation of the SdeXY-HasF efflux system also active against ciprofloxacin and cefpirome.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biological Transport, Active; Cefpirome; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Gene Deletion; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Minocycline; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Selection, Genetic; Serratia Infections; Serratia marcescens; Tigecycline; Up-Regulation | 2010 |
Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Synergism; Gentamicins; Lipoglycopeptides; Meropenem; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxacillin; Rifampin; Thienamycins; Time Factors | 2010 |
Synergy of fosfomycin with other antibiotics for Gram-positive and Gram-negative bacteria.
Topics: Acinetobacter baumannii; Amikacin; Anti-Bacterial Agents; Bacteria; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Enterobacteriaceae; Fosfomycin; Gentamicins; Gram-Negative Bacteria; Methicillin Resistance | 2010 |
Emergence of extended-spectrum beta-lactamase and fluoroquinolone resistance genes among Irish multidrug-resistant isolates.
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Genes, Bacterial; Genotype; Humans; Ireland; Microbial Sensitivity Tests; Prevalence | 2010 |
Detection of class 1 and 2 integrons, extended-spectrum β-lactamases and qnr alleles in enterobacterial isolates from the digestive tract of Intensive Care Unit inpatients.
Topics: Alleles; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Gastrointestinal Tract; Humans; Integrons; Intensive Care Units; Uruguay | 2010 |
Characteristics and dissemination of mosaic penicillin-binding protein 2-harboring multidrug-resistant Neisseria gonorrhoeae isolates with reduced cephalosporin susceptibility in northern Taiwan.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Penicillins; Sexually Transmitted Diseases, Bacterial; Taiwan | 2010 |
[Multiple brain abscesses complicating Enterobacter cloacae sepsis in a premature infant].
Topics: Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Infant; Infant, Newborn; Infant, Premature; Treatment Outcome | 2010 |
Melioidosis presenting as sepsis syndrome: a case report.
Topics: Anti-Bacterial Agents; Bacteremia; Burkholderia pseudomallei; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Humans; Male; Melioidosis; Microbial Sensitivity Tests; Middle Aged; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Antibiotic prescribing for adults with acute cough/lower respiratory tract infection: congruence with guidelines.
Topics: Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Cough; Drug Resistance, Bacterial; Europe; Female; Guideline Adherence; Humans; Male; Middle Aged; Primary Health Care; Prospective Studies; Respiratory Tract Infections; Tetracycline | 2011 |
Resistance to ampicillin, third-generation cephalosporins, ciprofloxacin, co-trimoxazole and azithromycin in clinical isolates of Salmonella enterica subsp. enterica from Germany: real problem or sporadic circumstance?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Ampicillin Resistance; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Germany; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Salmonella enterica; Salmonella Infections; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2011 |
How leaky gut and endotoxemia induce bacterial infection in cirrhosis and gastrointestinal hemorrhage?
Topics: Administration, Oral; Anti-Bacterial Agents; Bacterial Infections; Bacterial Translocation; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Endotoxemia; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Intestines; Liver Cirrhosis; Permeability; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2011 |
Impact of evaluating antibiotic concentrations in abdominal abscesses percutaneously drained.
Topics: Abdominal Abscess; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Exudates and Transudates; Female; Fluconazole; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Suction; Treatment Outcome; Vancomycin | 2011 |
[Features of clinic, diagnostics and treatment of typhoid fever in young patients].
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Hospitalization; Humans; Male; Typhoid Fever | 2011 |
Comamonas testosteroni infection in Taiwan: Reported two cases and literature review.
Topics: Aged; Alcoholism; Anti-Bacterial Agents; Bacteremia; Carcinoma, Hepatocellular; Cellulitis; Cephalosporins; Ciprofloxacin; Comamonas testosteroni; Gram-Negative Bacterial Infections; Hepatitis B, Chronic; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Middle Aged; Taiwan; Treatment Outcome | 2011 |
Occurrence & antibiogram of Salmonella Typhi & S. Paratyphi A isolated from Rourkela, Orissa.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Drug Resistance, Multiple; Fever; Humans; Incidence; India; Microbial Sensitivity Tests; Paratyphoid Fever; Salmonella paratyphi A; Salmonella typhi; Sanitation; Typhoid Fever; Water Pollutants | 2011 |
Antimicrobial resistance and prevalence of virulence factor genes in fecal Escherichia coli of Holstein calves fed milk with and without antimicrobials.
Topics: Animals; Animals, Suckling; Anti-Infective Agents; Cattle; Cefepime; Cephalosporins; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; DNA Gyrase; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Feces; Milk; Phylogeny; Virulence Factors | 2011 |
Wide dissemination of multidrug-resistant Shigella isolates in China.
Topics: Anti-Bacterial Agents; Bacterial Typing Techniques; Base Sequence; beta-Lactamases; Cephalosporins; China; Ciprofloxacin; Clavulanic Acids; DNA Gyrase; DNA Topoisomerase IV; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Dysentery, Bacillary; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Humans; Microbial Sensitivity Tests; Mutation; Quinolones; Sequence Analysis, DNA; Serotyping; Shigella flexneri | 2011 |
Underdosing of common antibiotics for obese patients in the ED.
Topics: Anti-Bacterial Agents; Bacterial Infections; Body Weight; Cefazolin; Cefepime; Cephalosporins; Ciprofloxacin; Emergency Service, Hospital; Humans; Obesity; Retrospective Studies | 2012 |
Emergence of spontaneous bacterial peritonitis due to enterococci - risk factors and outcome in a 12-year retrospective study.
Topics: Aged; Analysis of Variance; Anti-Infective Agents; Ascitic Fluid; Cephalosporins; Ciprofloxacin; Enterococcus; Female; Germany; Gram-Positive Bacterial Infections; Humans; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Peritonitis; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2012 |
[Microbiological monitoring in therapy of patients with iatrogenic esophageotracheal fistula].
Topics: Acetamides; Anti-Bacterial Agents; Candida; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Enterobacteriaceae; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Iatrogenic Disease; Imipenem; Intubation, Intratracheal; Linezolid; Microbial Sensitivity Tests; Monitoring, Physiologic; Oxazolidinones; Polymyxin B; Pseudomonas aeruginosa; Respiratory Tract Infections; Staphylococcus aureus; Staphylococcus epidermidis; Tracheoesophageal Fistula; Vancomycin | 2012 |
Cutaneous abscess leading to sepsis by Aeromonas hydrophila.
Topics: Abscess; Aeromonas hydrophila; Cefepime; Cephalosporins; Ciprofloxacin; Fever; Gram-Negative Bacterial Infections; Humans; Male; Microbial Sensitivity Tests; Sepsis; Skin Diseases, Bacterial; Young Adult | 2013 |
Antimicrobial susceptibility pattern and distribution of exoU and exoS in clinical isolates of Pseudomonas aeruginosa at a Malaysian hospital.
Topics: ADP Ribose Transferases; Adult; Anti-Bacterial Agents; Bacterial Proteins; Bacterial Toxins; Cefepime; Ceftazidime; Cephalosporins; Chi-Square Distribution; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gentamicins; Hospitals; Humans; Malaysia; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Pseudomonas aeruginosa | 2012 |
Multiplex bead suspension array for screening Neisseria gonorrhoeae antibiotic resistance genetic determinants in noncultured clinical samples.
Topics: Alleles; Anti-Infective Agents; Azithromycin; Cefixime; Cephalosporins; Chromosomes, Bacterial; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillins; Plasmids; Reproducibility of Results; Sensitivity and Specificity; Sequence Analysis, DNA; Spectinomycin; Tetracycline | 2013 |
Characteristics of ciprofloxacin and cephalosporin resistant Escherichia coli isolated from turkeys in Great Britain.
Topics: Animals; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Genotype; Microbial Sensitivity Tests; Phenotype; Serotyping; Turkeys; United Kingdom | 2013 |
Risk factors for antimicrobial resistance in Escherichia coli found in GB turkey flocks.
Topics: Animal Husbandry; Animals; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Models, Statistical; Poultry Diseases; Risk Factors; Surveys and Questionnaires; Turkeys; United Kingdom | 2013 |
Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Switzerland; Young Adult | 2013 |
Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Phenotype; Switzerland; Tetracycline; Young Adult | 2014 |
Antimicrobial susceptibility of Salmonella isolates from healthy pigs and chickens (2008-2011).
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; Belgium; beta-Lactamases; Cephalosporins; Chickens; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Feces; Humans; Microbial Sensitivity Tests; Salmonella; Species Specificity; Sus scrofa; Swine | 2014 |
Treatment failure due to induction of ciprofloxacin resistance during combination therapy with colistin and ciprofloxacin in multidrug-resistant Pseudomonas aeruginosa bacteraemia.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Ciprofloxacin; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Meropenem; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Failure | 2014 |
Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with acute myeloid leukemia.
Topics: Administration, Oral; Adolescent; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Candidiasis; Cefepime; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Ciprofloxacin; Consolidation Chemotherapy; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Incidence; Induction Chemotherapy; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Neoplasm Staging; Nose; Outpatients; Rectum; Retrospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2014 |
Microbacterium spp. as a cause of peritoneal-dialysis-related peritonitis in two patients.
Topics: Acinetobacter; Actinobacteria; Aged, 80 and over; Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Penicillins; Peritoneal Dialysis; Peritonitis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Vancomycin | 2016 |
Epidemic and virulence characteristic of Shigella spp. with extended-spectrum cephalosporin resistance in Xiaoshan District, Hangzhou, China.
Topics: Adolescent; Adult; Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporin Resistance; Cephalosporins; Child; Child, Preschool; China; Ciprofloxacin; Dysentery, Bacillary; Female; Galanin; Genes, Bacterial; Genotype; Humans; Male; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Polymerase Chain Reaction; Shigella; Substance P; Virulence | 2014 |
Osteomyelitis of the clavicle following to a pacemaker implantation.
Topics: Anti-Bacterial Agents; Cardiac Pacing, Artificial; Cefepime; Cephalosporins; Ciprofloxacin; Clavicle; Drug Therapy, Combination; Equipment Design; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteomyelitis; Pacemaker, Artificial; Pseudomonas aeruginosa; Pseudomonas Infections | 2014 |
Ceftriaxone Potentiates Warfarin Activity Greater Than Other Antibiotics in the Treatment of Urinary Tract Infections.
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Synergism; Drug Therapy, Combination; Humans; International Normalized Ratio; Penicillins; Retrospective Studies; Urinary Tract Infections; Warfarin | 2016 |
Susceptibility of Escherichia coli from community-acquired urinary tract infection to fosfomycin, nitrofurantoin, and temocillin in Korea.
Topics: Anti-Bacterial Agents; Cefepime; Cell Survival; Cephalosporins; Ciprofloxacin; Community-Acquired Infections; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Fosfomycin; Humans; Nitrofurantoin; Penicillins; Republic of Korea; Sulfadoxine; Treatment Outcome; Trimethoprim; Urinary Tract Infections | 2014 |
Quantification of piperacillin, tazobactam, cefepime, meropenem, ciprofloxacin and linezolid in serum using an isotope dilution UHPLC-MS/MS method with semi-automated sample preparation.
Topics: Analytic Sample Preparation Methods; Anti-Bacterial Agents; Automation; Blood Chemical Analysis; Cefepime; Cephalosporins; Chromatography, High Pressure Liquid; Ciprofloxacin; Humans; Isotopes; Linezolid; Meropenem; Penicillanic Acid; Piperacillin; Tandem Mass Spectrometry; Tazobactam; Thienamycins; Time Factors | 2015 |
Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Europe; European Union; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance | 2014 |
Genetic profiles of fluoroquinolone-nonsusceptible Klebsiella pneumoniae among cephalosporin-resistant K. pneumoniae.
Topics: Amino Acid Substitution; Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Genes, Bacterial; Japan; Klebsiella pneumoniae; Quinolones | 2015 |
Cefepime induced acute interstitial nephritis--a case report.
Topics: Acute Kidney Injury; Cefepime; Cephalosporins; Ciprofloxacin; Escherichia coli Infections; Female; Humans; Infusions, Intravenous; Kidney Function Tests; Mastoiditis; Middle Aged; Nephritis, Interstitial; Rare Diseases; Risk Assessment; Treatment Outcome; Withholding Treatment | 2015 |
[Prophylaxis of purulent complications in mechanical ileus].
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Biological Transport; Cephalosporins; Ciprofloxacin; Disease Models, Animal; Fluoroquinolones; Gentamicins; Ileus; Peritonitis; Permeability; Rats; Rats, Wistar | 2015 |
Extended-Spectrum ß-Lactamase, AmpC-Producing, and Fluoroquinolone-Resistant Escherichia coli in Retail Broiler Chicken Meat, Italy.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Chickens; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Escherichia coli; Food Contamination; Food Microbiology; Genotyping Techniques; Italy; Phylogeny; Plasmids; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Poultry; Virulence Factors | 2015 |
Risk factors and clinical significance of bacteremia caused by Pseudomonas aeruginosa resistant only to carbapenems.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Blood Culture; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Case-Control Studies; Cephalosporins; Ciprofloxacin; Cross Infection; Female; Hospitals; Humans; Imipenem; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Mortality; Multivariate Analysis; Odds Ratio; Penicillins; Pseudomonas aeruginosa; Pseudomonas Infections; Retrospective Studies; Risk Factors; Severity of Illness Index; Taiwan; Thienamycins | 2017 |
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns.
Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection | 2016 |
Rapid increase in resistance to third generation cephalosporins, imipenem and co-resistance in Klebsiella pneumoniae from isolated from 7,140 blood-cultures (2010-2014) using EARS-Net data in Spain.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactam Resistance; beta-Lactamases; Catchment Area, Health; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross Infection; Drug Resistance, Multiple, Bacterial; Female; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Population Surveillance; Spain; Young Adult | 2017 |
Antimicrobial resistance of Neisseria gonorrhoeae isolates in south-west Germany, 2004 to 2015: increasing minimal inhibitory concentrations of tetracycline but no resistance to third-generation cephalosporins.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Azithromycin; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Germany, West; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Penicillins; Tetracycline; Tetracyclines; Treatment Outcome | 2016 |
Antimicrobial Susceptibility of Microorganisms Isolated from Periapical Periodontitis Lesions.
Topics: Actinomyces; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biofilms; Campylobacter; Cefmetazole; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Bacterial; Fusobacteria; Haemophilus; Humans; Klebsiella; Microbial Sensitivity Tests; Ofloxacin; Periapical Periodontitis; Porphyromonas; Propionibacterium; Staphylococcus hominis; Veillonella | 2016 |
Risk Factor Analysis of Ciprofloxacin-Resistant and Extended Spectrum Beta-Lactamases Pathogen-Induced Acute Bacterial Prostatitis in Korea.
Topics: Acute Disease; Adult; Age Factors; Aged; Amikacin; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Humans; Imipenem; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Odds Ratio; Prostatitis; Republic of Korea; Retrospective Studies; Risk Factors | 2016 |
The Antimicrobial Susceptibility of Klebsiella pneumoniae from Community Settings in Taiwan, a Trend Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Genetic Variation; Humans; Klebsiella Infections; Klebsiella pneumoniae; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Population Surveillance; Taiwan; Urine; Young Adult | 2016 |
First Detection of GES-5 Carbapenemase-Producing Acinetobacter baumannii Isolate.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Colistin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Gene Expression; Hospitals; Humans; Isoenzymes; Microbial Sensitivity Tests; Minocycline; Molecular Epidemiology; Multilocus Sequence Typing; Saudi Arabia; Serogroup; Tigecycline | 2017 |
Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cephalosporins; Ciprofloxacin; Clone Cells; Cross Infection; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Multiple, Bacterial; Gene Expression; Hospitals, Teaching; Humans; Isoenzymes; Malaysia; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Plasmids; Sequence Analysis, DNA | 2017 |
Resurgence of Neisseria meningitidis serogroup W ST-11 (cc11) in Madagascar, 2015-2016.
Topics: Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacterial Typing Techniques; Cephalosporins; Ciprofloxacin; Disease Outbreaks; Female; Genotype; Humans; Incidence; Infant; Madagascar; Male; Meningococcal Infections; Molecular Epidemiology; Neisseria meningitidis | 2017 |
Codon 91 Gyrase A Testing Is Necessary and Sufficient to Predict Ciprofloxacin Susceptibility in Neisseria gonorrhoeae.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Codon; Fluoroquinolones; Genomics; Gonorrhea; Humans; Macrolides; Neisseria gonorrhoeae; United States | 2017 |
Medial prefrontal cortex and dorsomedial striatum are necessary for the trial-unique, delayed nonmatching-to-location (TUNL) task in rats: role of NMDA receptors.
Topics: Animals; Cephalosporins; Choice Behavior; Ciprofloxacin; Conditioning, Operant; Corpus Striatum; Dose-Response Relationship, Drug; Male; Piperazines; Prefrontal Cortex; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Space Perception; Touch; Valine | 2017 |
Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; beta-Lactamases; Cephalosporins; China; Ciprofloxacin; Drug Resistance, Bacterial; Genotype; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Epidemiology; Mutation; Neisseria gonorrhoeae; Penicillins; Repressor Proteins; Spectinomycin; Tetracycline | 2017 |
Spectrum and antibiotic resistance of uropathogens between 2004 and 2015 in a tertiary care hospital in Hungary.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Humans; Hungary; Klebsiella pneumoniae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Retrospective Studies; Tertiary Care Centers; Urinary Tract Infections; Urine | 2017 |
Semi-quantitative MALDI-TOF for antimicrobial susceptibility testing in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Oxacillin; Sensitivity and Specificity; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2017 |
Prevalence and Transmission of Antimicrobial Resistance in a Vertically Integrated Veal Calf Production System.
Topics: Abattoirs; Animals; Anti-Bacterial Agents; Cattle; Cefepime; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Escherichia coli; Feces; Food Contamination; Food Microbiology; Food Supply; Foodborne Diseases; Genes, Bacterial; Male; Prospective Studies; Red Meat; United States | 2017 |
Topics: Anti-Bacterial Agents; Cefepime; Ceftazidime; Cephalosporins; Ciprofloxacin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Febrile Neutropenia; Humans; Iatrogenic Disease; Meropenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia; Practice Guidelines as Topic; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tazobactam; Thienamycins; Tobramycin | 2017 |
Efficacy of Ceftriaxone, Cefepime, Doxycycline, Ciprofloxacin, and Combination Therapy for Vibrio vulnificus Foodborne Septicemia.
Topics: Animals; Anti-Bacterial Agents; Cefepime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Doxycycline; Drug Synergism; Drug Therapy, Combination; Female; Foodborne Diseases; Humans; Mice; Seafood; Sepsis; Vibrio Infections; Vibrio vulnificus | 2017 |
A Comparison of Real-Time Polymerase Chain Reaction Assays for the Detection of Antimicrobial Resistance Markers and Sequence Typing From Clinical Nucleic Acid Amplification Test Samples and Matched Neisseria gonorrhoeae Culture.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Typing Techniques; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; False Positive Reactions; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Mutation; Neisseria gonorrhoeae; Real-Time Polymerase Chain Reaction; Sensitivity and Specificity | 2018 |
Empiric antibiotic therapy in urinary tract infection in patients with risk factors for antibiotic resistance in a German emergency department.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Area Under Curve; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Emergency Service, Hospital; Female; Fluoroquinolones; Gentamicins; Germany; Humans; Male; Middle Aged; Odds Ratio; Penicillanic Acid; Piperacillin; Risk Factors; ROC Curve; Tazobactam; Urinary Tract Infections | 2018 |
Investigation of a typhoid fever epidemic in Moyale Sub-County, Kenya, 2014-2015.
Topics: Abdominal Pain; Adolescent; Adult; Anti-Bacterial Agents; Cephalosporins; Child; Ciprofloxacin; Commerce; Disease Outbreaks; Endemic Diseases; Epidemics; Female; Fever; Gastrointestinal Diseases; Humans; Hygiene; Kenya; Male; Middle Aged; Salmonella typhi; Sanitation; Typhoid Fever; Water Supply; Young Adult | 2018 |
Detection of TEM and CTX-M genes from ciprofloxacin resistant Proteus mirabilis and Escherichia coli isolated on urinary tract infections (UTIs).
Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Genes, Bacterial; Humans; Klebsiella pneumoniae; Microbial Sensitivity Tests; Proteus mirabilis; Urinary Tract Infections | 2018 |
Molecular screening for Neisseria gonorrhoeae antimicrobial resistance markers in Nigerian men who have sex with men and transgender women.
Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Nigeria; Nucleic Acid Amplification Techniques; Penicillins; Real-Time Polymerase Chain Reaction; Transgender Persons; Young Adult | 2018 |
AmpC beta-lactamases in Klebsiella pneumoniae: An emerging threat to the paediatric patients.
Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefoperazone; Cefoxitin; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Cross-Sectional Studies; Disk Diffusion Antimicrobial Tests; Drug Combinations; Drug Resistance, Bacterial; Female; Hospitals, Pediatric; Humans; Imipenem; Infant; Infant, Newborn; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Male; Meropenem; Microbial Sensitivity Tests; Pakistan; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2018 |
Emergence of
Topics: Anti-Bacterial Agents; Cephalosporins; Chloramphenicol; Chromosome Mapping; Chromosomes, Bacterial; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae Infections; Gene Transfer, Horizontal; Genomic Islands; Humans; Integrons; Male; Morganella morganii; Proteus Infections; Providencia; Salmonella typhimurium; Thiamphenicol | 2019 |
Antimicrobial resistance and molecular characteristics of Neisseria gonorrhoeae isolates from men who have sex with men.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Azithromycin; Bacterial Proteins; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Repressor Proteins; Sequence Analysis, DNA; Spectinomycin; Tetracycline | 2019 |
Combination therapy with ciprofloxacin and third-generation cephalosporin versus third-generation cephalosporin monotherapy in Escherichia coli meningitis in infants: a multicentre propensity score-matched observational study.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Therapy, Combination; Escherichia coli; Humans; Infant; Infant, Newborn; Meningitis, Escherichia coli; Multivariate Analysis; Propensity Score; Prospective Studies; Retrospective Studies | 2019 |
Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: a case report.
Topics: Aged; Anti-Bacterial Agents; Antibody Specificity; Antifungal Agents; Autoantibodies; Autoimmune Diseases; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Substitution; Drug Therapy, Combination; Factor V; Factor V Deficiency; Fluoroquinolones; Humans; Levofloxacin; Male; Meropenem; Micafungin; Partial Thromboplastin Time; Pneumonia; Prothrombin Time | 2019 |
Exploitation of Antibiotic Resistance as a Novel Drug Target: Development of a β-Lactamase-Activated Antibacterial Prodrug.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Escherichia coli; Hydrolysis; Microbial Sensitivity Tests; Molecular Structure; Prodrugs; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2019 |
Antibiotic selection and isolate susceptibility profile in patients who failed ciprofloxacin or TMP-SMX for pyelonephritis.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Emergency Service, Hospital; Humans; Pyelonephritis; Trimethoprim, Sulfamethoxazole Drug Combination | 2019 |
Topics: Adult; Alleles; Anti-Bacterial Agents; Cephalosporins; Chlamydia trachomatis; Ciprofloxacin; Coinfection; DNA, Bacterial; Drug Resistance, Bacterial; Female; Fluoroquinolones; Genes, Bacterial; Genotype; Humans; Italy; Macrolides; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Mutation; Neisseria gonorrhoeae; Pilot Projects; Young Adult | 2019 |
Outcomes of Third-Generation Cephalosporin Plus Ciprofloxacin or Doxycycline Therapy in Patients with Vibrio vulnificus Septicemia: A Propensity Score-Matched Analysis.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Case-Control Studies; Cephalosporins; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Republic of Korea; Retrospective Studies; Sepsis; Treatment Outcome; Vibrio Infections; Vibrio vulnificus; Young Adult | 2019 |
Local outbreak of extended-spectrum β-lactamase SHV2a-producing Pseudomonas aeruginosa reveals the emergence of a new specific sub-lineage of the international ST235 high-risk clone.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Bacterial Proteins; beta-Lactamases; Ceftazidime; Cephalosporins; Ciprofloxacin; Colistin; Cross Infection; Disease Outbreaks; Drug Combinations; Drug Resistance, Multiple, Bacterial; Female; France; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Polymorphism, Single Nucleotide; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2020 |
Effect of Ceftaroline, Vancomycin, Gentamicin, Macrolides, and Ciprofloxacin against Methicillin-Resistant
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Genes, Bacterial; Gentamicins; Humans; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Vancomycin | 2020 |
Resistance to third-generation cephalosporins in Escherichia coli in the French community: The times they are a-changin'?
Topics: Anti-Bacterial Agents; beta-Lactamases; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; France; Humans; Microbial Sensitivity Tests; Nalidixic Acid; Outpatients; Prevalence; Retrospective Studies | 2020 |
Primary Infectious Acute Pancreatitis: A 9 Case Series.
Topics: Acute Disease; Acyclovir; Adult; Anti-Bacterial Agents; Antiviral Agents; Bacterial Infections; Cephalosporins; Ciprofloxacin; Female; Humans; Male; Pancreatitis; Retrospective Studies; Tertiary Care Centers; Treatment Outcome; Virus Diseases | 2020 |
The phenotypic and molecular characteristics of antimicrobial resistance of Salmonella enterica subsp. enterica serovar Typhimurium in Henan Province, China.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Child; Child, Preschool; China; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Salmonella; Salmonella Infections; Serogroup; Young Adult | 2020 |
Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test samples.
Topics: Anti-Bacterial Agents; Azithromycin; Canada; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Real-Time Polymerase Chain Reaction | 2020 |
Efficacy of sub-MIC level of meropenem and ciprofloxacin against extensive drug-resistant (XDR) Pseudomonas aeruginosa isolates of diabetic foot ulcer patients.
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Diabetic Foot; Drug Resistance; Humans; Meropenem; Microbial Sensitivity Tests; Piperacillin; Pseudomonas aeruginosa; Pseudomonas Infections; Tazobactam | 2021 |
In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens.
Topics: Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Biological Warfare Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Plague; Siderophores; Yersinia pestis | 2021 |
Molecular Surveillance and Prediction of Antimicrobial Resistance of Neisseria gonorrhoeae in Northern Alberta, Canada, 2015 to 2018.
Topics: Alberta; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 2022 |
Prevalence and molecular characterization of foodborne and human-derived Salmonella strains for resistance to critically important antibiotics.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Carbapenems; Cattle; Cephalosporins; Ciprofloxacin; Colistin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Monobactams; Prevalence; Rabbits; Salmonella; Salmonella enterica; Tetracyclines | 2022 |
[The postal code as a "bar code" of antimicrobial resistance].
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins | 2022 |
Evolution of Beta-Lactamases in Urinary Klebsiella pneumoniae Isolates from Croatia; from Extended-Spectrum Beta-Lactamases to Carbapenemases and Colistin Resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cephalosporins; Ciprofloxacin; Clavulanic Acid; Colistin; Croatia; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests | 2022 |
Association between antimicrobial consumption and resistance rate of Escherichia coli in hospital settings.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Escherichia coli; Fluoroquinolones; Hospitals; Humans; Microbial Sensitivity Tests | 2023 |
Identification and Genetic Characterization of Conjugative Plasmids Encoding Coresistance to Ciprofloxacin and Cephalosporin in Foodborne
Topics: Anti-Bacterial Agents; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Monobactams; Plasmids; Quinolones; Vibrio | 2023 |